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ABSTRACT 
Introduction 
Mother to Child Transmission is a significant route of HIV infection in children and in South 
Africa (SA) the median HIV prevalence rate among pregnant women is 30, 2% and in the 
Western Cape Province (WCP) it is 18, 2%. Although Prevention of Mother to Child 
Transmission (PMTCT) programmes are now available at 100% of all health care facilities and 
95% of women attend antenatal care, these programmes are complex and outcome data reveals 
fluctuations in transmission rates as well as pockets of high transmission within well performing 
sub-districts. The careful management of programme processes thus requires more than coverage 
and outcome data. It also requires a clear picture of process indicators related to access to 
PMTCT services, the quality and continuity of care within the PMTCT programme and 
integration of PMTCT service into the comprehensive package of health care services. 
Aims and objectives 
To develop a tool that will measure the quality of care of HIV exposed infants in the PMTCT 
programme at primary care setting in Cape Town, by engaging local programme managers in a 
participatory process to develop a tool that is locally applicable and relevant, and captures local 
management expertise. To identify the evaluation domains, to develop a set of indicators for each 
domain and to pilot the tool to assess its feasibility and usefulness of the data generated. 
Methodology  
Study design: The study design for developing this tool was Participatory Research and the 
knowledge of local experts formed the basis of the research and planning. This study design best 
suited the four phases of tool development and validation.  
Population and sample: The participants in the tool design (the „core task team‟) were 
purposefully selected as provincial and district HIV, AIDS, STI and TB (HAST) programme 
managers and academics who had been involved in the development of a previous integrated 
HAST audit. A second group of participants involved in piloting and validating (the 
„implementers‟) were purposefully selected as end-users of the tool: facility managers and sub 
district HAST coordinators. The target population for which the tool was developed was the HIV 
exposed infants on the PMTCT programme within the primary care setting in Cape Town.  
Data collection process: The literature review revealed that a tool that would serve this purpose 
was not available.  The „core task team‟ and „implementers‟ developed the tool using the steps 
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proposed by Benson and Clark (1982) in a continuous analysis process involving panel 
discussions and post pilot sessions. The researcher facilitated each of the sessions in a manner 
that afforded each of the group members an equal opportunity to express their opinion. At each 
of these sessions, robust discussions on each of the tracer indicators within the agreed domains 
took place, until a decision was taken on the best way forward. 
Ethics  
Procedural ethics was provided by the Higher Degrees Research Committee at UWC. 
Confidentiality of all client records reviewed during the piloting of the tool was maintained. 
Each participant received an information sheet and completed a consent form. During this study 
the contributions made by the HAST experts and facility level staff were equally respected and 
this contributed towards improved quality assurance and health system strengthening.  
Results 
Following this series of sessions, a tool that could evaluate the quality of the PMTCT 
programmes offered to the HIV exposed infant in the primary health facility setting, was 
developed. The piloting of this PMTCT Baby tool showed that the tool was feasible and 
provided useful information that would guide decision-making at facility, sub-district, sub-
structure and provincial level, in order to effect quality improvement. The tool has been 
considered to be valid and reliable and is applicable to the primary setting across the Western 
Cape Province.  
Conclusion: 
The PMTCT Baby tool has captured the expertise and experience of programme HAST 
managers responsible for developing, monitoring and strengthening the local PMTCT 
programme, as well as those responsible for implementing the programme. It is recommended 
for inclusion into the Integrated HAST audit tool by the implementers and will become part of all 
future auditing of the HAST programmes. It is evident that implementation guidelines are 
essential in order to ensure that the PMTCT policy is implemented as intended.  
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CHAPTER 1:  INTRODUCTION 
 
1.1 Problem 
HIV is a major disease burden in Sub-Saharan Africa (SSA), with South Africa (SA) having one 
of the highest community prevalences of 10, 2% of the total population according to the 
Statistics South Africa (Stats SA, 2011) mid-year estimates. Mother to Child Transmission 
(MTCT) is a significant route of infection in children with between 10-40% transmission rates in 
the absence of medical intervention. The median HIV prevalence rate among pregnant women in 
SA is 30, 2% and 18, 5% in the Western Cape Province (WCP) (DoH, 2011).  
 
Ninety percent of the world‟s 800 000 paediatric cases of AIDS are in SSA, an area that is 
challenged by a high HIV prevalence among pregnant women within an under-resourced health 
care infrastructure (UNAIDS, 2010). Prevention of Mother to Child Transmission (PMTCT) is 
one of the key interventions implemented in order to achieve a two thirds reduction in the under 
5 mortality by 2015 (the 4
th
 Millennium Development Goal). Before PMTCT programmes had 
been implemented, the MTCT rate from HIV positive breastfeeding mother to her infant ranged 
from 22, 2% to 30, 2% (UNAIDS, 2005). According to the South African National HIV 
Household Prevalence Survey conducted in 2008 (AVERT, 2009), 2, 5% of children aged 2 – 14 
years are already HIV positive.  
  
PMTCT programmes are efficacious (PETRA, 2002) and in SA these services are now available 
at all health care facilities (Goga et al, 2010). Since 95% of women attend antenatal care, it 
should be feasible to implement and track the PMTCT programme (Jackson et al, 2007). 
However the PMTCT programmes are complex and require a number of high quality health 
system interventions across the service platform ranging from antenatal, intra-partum, post-natal, 
baby follow-up at well baby clinics and follow-up for the mother after delivery (Jackson et al, 
2007).  
 
Rollins, et al (2002) emphasise the imperative for thorough monitoring of PMTCT interventions. 
They state that surveys, sentinel site reports, cohort studies and routine data are often costly and 
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lack information that would guide decision-makers and funders. According to Stringer et al 
(2008) there is a lack of consensus on how to monitor the effectiveness of PMTCT programmes, 
since it involves a complex critical pathway. 
 
1.2 Local Setting 
1.2.1   The Metro District 
This research is set in the WCP which has 6 districts of which the Metro District is the largest. 
Within the Metro District there are 2 health authorities that render primary care services to the 
uninsured population at 147 primary care facilities. These are the Provincial Government – 
Metro District Health Services (MDHS) and Local Government - City of Cape Town: Health 
(CoCT). The Metro District consists of eight health sub-districts and within the MDHS, two 
health sub-districts form a health sub-structure. There are thus four health sub-structures which 
each function as a complete management unit, equivalent to that of a health district. Within the 
CoCT, each health sub-district comprises of a management unit for the local government health 
services, but with a strategic and clearly defined link into each of the four health sub-structures.  
 
Services across this primary care platform are predominantly nurse-driven and doctor-supported 
and are seen as the entry point into health care. Referrals for further management are made into 
the secondary and tertiary level of care, from the primary care platform. 
 
1.2.2   Health Programmes Support to the Metro District   
The Western Cape Department of Health (WCDoH) provincial level comprises of a Chief 
Directorate: Health Programmes, which provides support to all the health districts including the 
sub-structures within the Metro District with regards to: 
- policy development, 
- provision of relevant guidelines, tools and standard operating procedures,  
- monitoring and evaluation of health programmes, health outputs and outcomes,  
- programme management and financial and human resource acquisition and allocation. 
 
At the sub-structure level, programme managers are in place for various health programmes. 
They are responsible for providing technical programme support to the sub-district programme 
 
 
 
 
 Page 3 
 
coordinators on the operationalization of policy; feed into policy development at the provincial 
level; ensure human and financial resource prioritisation and allocation; contract manage the  
external health care providers including non-profit organisations (NPO) and monitor and 
evaluate  sub-structure level health programmes.   
 
On sub-district level there are two HIV, AIDS, STI and TB (HAST) programme coordinators 
who provide direct support to all facility managers in the actual implementation of policy; 
monitor and evaluate health programme outputs and provide training related to the 
implementation and sustaining of health programmes. There is also a PMTCT coordinator who 
functions across the Sub-Structure providing direct support to facility management with regards 
to PMTCT specifically.  
 
1.2.3   The PMTCT Programme 
The WCP has the flagship PMTCT programme in SA (WCDoH, 2009). One of the sub districts 
within the WCP was the first to pilot PMTCT in SA and by 2003 all maternal and infant service 
sites in the WCP had PMTCT service coverage.  
Diagram 1.1: PMTCT programme summary (Developed by C. Goosen: WCP PMTCT Manager, May 2012) 
 
 
 
 
 
 Page 4 
 
AZT:  Zidovudine, an antiretroviral drug used to prevent MTCT of HIV 
CD4: Number of T-helper lymphocytes per cubic millilitre of blood. A test conducted to determine the number of fighter cells in 
the blood of an HIV infected individual 
WHO Stage: World Health Organisation Stage. The different stages of HIV infection 
TB:  Tuberculosis. A contagious bacterial infection that involves the lungs 
ART:  Antiretroviral treatment. A variety of drugs that reduce the amount of HI Virus in the body fluid 
AFB:  Acid-fast bacilli. A test to detect TB in sputum 
sdNVP:  Single dose Nevirapine. Antiretroviral drug used to prevent mother to child transmission of HIV 
TDF and FTC: Tenofovir and Emtricitabine otherwise known as Truvada®. Antiretroviral drug used to prevent MTCT of HIV 
LL:  Lifelong. As long as the person lives 
CTX:  Co-Timoxazole. An anti-bacterial drug that is used prophylactically in HIV exposed infants to prevent bacterial infection 
Pos:  Positive.  The presence of HIV in the blood. 
Neg:  Negative. The absence of HIV in the blood. 
TTO:  To Take Out. Medication given on discharge from hospital to be continued at home 
BF:  Breastfeeding. Infant feeding from the mother‟s breast. 
PCR:  Polymerase Chain Reaction. A test conducted to detect HIV in the infant‟s blood at 6 weeks age. 
 
Based on the PMTCT policy guidelines (WCDoH, 2011), diagram 1.1 provides a summary of 
the PMTCT programme. The mother is introduced to the PMTCT programme on testing HIV 
positive during the antenatal booking visit, registered onto the Antenatal HIV Counselling and 
Testing (HCT) register and monitored throughout her pregnancy. Her immune status is 
determined by her CD4 count and based on this the mother is either commenced on dual 
antiretroviral treatment (ART), which is referred to as PMTCT ART, for the duration of her 
pregnancy or lifelong ART. In the labour ward, the mother on PMTCT ART will receive a short 
course of prophylactic antiretroviral (ARV) drugs to prevent transmission while the mother on 
lifelong ART will continue with her regimen as prescribed. The new born infant is started on a 
single ARV drug as prophylaxis to prevent HIV infection and is continued on this drug for 6 
weeks when an HIV Polymerase Chain Reaction (PCR) test is conducted and then commenced 
on Co-trimoxazole, a drug to prevent opportunistic infections. If the infant is breastfeeding, then 
the drugs are continued until one week after breastfeeding has stopped. With an HIV PCR 
positive result, the infant is either fast tracked for referral and commencement on ART and with 
an HIV PCR negative result, the infant is followed up and tested for HIV after cessation of 
breastfeeding. All infants who test HIV PCR negative are tested at 18 months with an HIV rapid 
test.  
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Paper based registers in the antenatal setting, labour ward and baby clinics, track all clients 
(mothers and infants) registered on the PMTCT programme and provide programme coverage 
and outcome indicators as follows: 
- Proportion of HIV positive pregnant women receiving adequate Zidovudine (AZT) 
antenatally 
- Proportion of HIV positive pregnant women receiving NVP stat intra-partum 
- Proportion of HIV positive mothers accessing adequate dual therapy 
- HIV transmission rate to the HIV exposed infant at 6 weeks 
(Personal communication with Brenda Smuts, previous Director HIV & AIDS, STI and TB 
Programme, for the WCDoH, 3 March 2010).  
 
1.2.4   Purpose of the Study 
The strength of the HIV programme within the WCP is due to the fact that the health authorities 
and academic institutions placed significant emphasis on managing and improving the 
programme through monitoring and evaluation. As far back as 2002 the local and provincial 
health department programme managers and academics within the Metro District, saw the need 
to audit or evaluate the quality of care that clients receive within the Tuberculosis (TB) services 
in the Primary Health Care (PHC) setting. A tool was developed to look at the quality of care 
that the TB client received and was subsequently piloted in one sub district. The findings were 
utilized to improve service delivery through identifying areas for re-training, re-enforcement and 
improved management of services. However, the tool had required too much qualitative work 
and was thus deemed too detailed to apply throughout the entire Metro District.  
 
This experience then informed the approach to developing an integrated tool to evaluate a much 
broader scope of services: TB care, HCT, general HIV care, ARV care and STI services. The 
integrated tool made use of tracer indicators and was predominantly quantitative. 
 
In 2007 a PMTCT component was added which focussed on the quality of PMTCT care 
rendered in the antenatal unit and labour ward to HIV positive pregnant women on the PMTCT 
programme.  
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Graph 1.1: Mother to Child Transmission Rate from 2003 to 2010 (WCDoH Data set, 2011) 
 
 
In the WCP the PMTCT transmission rates, according to the WCDoH official data set, has 
shown a marked reduction in mother to child transmission from 17, 6% in 2003 down to 3, 2% in 
2010 (refer to Graph 1.1). Although this may paint a picture that the PMTCT programme within 
the WCP is well functioning and efficacious, analysis of quarterly coverage and outcome data 
reveals fluctuations within the year as well as pockets of high transmission within moderate to 
well performing sub-districts. PMTCT programmes are complex and there is a risk of suboptimal 
implementation which makes careful programme monitoring and management essential. This 
requires more than just process and outcome evaluation. In addition to this, the current official 
data set provides coverage and outcome data that predominantly focuses on the mother, with 
only minimal focus on the infant. Based on this, PMTCT programme managers felt that there 
was still room for improvement in the Metro District and an opportunity to learn lessons from the 
Metro District could also be shared with other provinces.  
 
An audit tool is currently in place to measure the quality of the PMTCT programmes rendered 
within the Antenatal Setting and the Labour Ward. The purpose of the development of the tool to 
evaluate the PMTCT services rendered to the HIV exposed infant was to measure the quality of 
care this infant received and in-so-doing contribute to the quality improvement of the PMTCT 
service offered within the primary care facility setting.   
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The WCP had developed considerable expertise in managing the implementation of the PMTCT 
programme, and an opportunity presented itself to capture this in a monitoring and evaluation 
tool which could be used to locally improve performance in the areas where transmission was 
still high, as well as in other provinces.  A PMTCT tool to evaluate the services rendered to the 
HIV exposed infant has thus been designed to dovetail with existing HAST tools for the 
following reasons: 
- One package evaluating all HAST programmes, could provide a uniform approach to 
quality assurance across the HAST programmes;  
- It would be easier for users to apply this tool, since they would be familiar with using the 
tool with the same design; 
- As with cause and effect, it would be beneficial to identify gaps within the quality of the 
other HAST programmes as a result of integration of services, that may reveal causes of 
poor performance within this particular programme area;  
- Certain aspects that would require evaluation could simply be latched onto existing 
components of the existing Integrated HAST audit tool. 
 
1.2.5 Outline of the study 
The literature review was conducted with a specific focus on process evaluation, programme 
effectiveness, the research process of developing a tool and a search for existing tools that would 
serve this purpose. The chapter on methodology includes a process flow of the study outlining 
the 4 sessions held with the HAST experts and the two pilots that were conducted (including the 
training session) in order to develop the three drafts of the tool. This is followed by a chapter 
which focuses on the results from the second pilot which ultimately informed the final tool. The 
chapter on discussion unpacks the process of developing the PMTCT baby tool, highlights the 
challenges in interpreting policy and determines the usefulness and applicability of the PMTCT 
baby tool. In the last chapter recommendations for the use of the tool are made, as well as actions 
that would improve the PMTCT programme. 
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CHAPTER 2:  LITERATURE REVIEW 
 
2.1 Introduction 
This literature review first looked at process evaluation and its stages and then it focused in more 
detail on quality assessment as a specific form of process evaluation. A further look ensued into 
defining programme effectiveness and its six stages, which was followed by a review of the most 
appropriate research processes for developing a tool. The last leg of the search located all 
published PMTCT tools internationally as well as unpublished PMTCT tools in SA that were 
available for use.   
 
2.2  Process Evaluation 
An evaluation is a process of systematically determining the effectiveness and impact of a set of 
activities as it relates to its goal/s (Bonita, Beaglehole & Kjellstrom, 2006). A process evaluation 
is the use of empirical data to assess health programme delivery and, unlike an outcome 
evaluation that assesses the impact of a programme, a process evaluation verifies whether the 
programme is being implemented according to designed or protocol (Bliss & Emshoff, 2002). 
The questions that must be answered when conducting process evaluation are: “what is the 
programme intended to be; what is delivered in reality and where are the gaps between 
programme design and delivery?” (Bliss & Emshoff, 2002:1). In order to answer these 
questions, use is made of qualitative and quantitative methods in process evaluation, since no one 
method can provide the same rich information (Linnan & Steckler, 2003).  
 
The main reasons for conducting process evaluation include the following (Bliss & Emshoff, 
2002): 
- The comparison of multiple sites with regards to fidelity 
- To provide validity for the relationship between programme intervention and the resultant 
outcomes 
- To provide managers with information on the quality surrounding implementation 
- To provide programme accountability to sponsors, the public, clients and funders 
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- Ultimately to improve the quality of the programme through evaluation which is also 
considered an intervention 
The proposed stages of process evaluation are as follows (Bliss & Emshoff, 2002): 
- Form strong collaborative relationships with the appropriate programme delivery and 
management staff and determine programme components 
- Develop logical model and evaluation questions 
- Determine the methodology and consider the management information system 
- Implement data collection and analysis and write the report 
 
Quality assessment is another form of process evaluation that is spoken of in the literature. In the 
context of Primary Health Care (PHC) it has been defined as a process whereby services are 
evaluated against a set of norms for quality care (AKF, 1993). These norms are often in the form 
of policies, guidelines and protocols. Katzenellenbogen et al (1997: 147), state that “evaluation 
is a systematic way of learning from experience”. This in essence means reflecting on work done 
and past experiences, in order to determine where problems lie and whether goals have been 
achieved. Planned activities are thus changed based on lessons learned and recommendations 
made from the evaluation process. Comparison standards are required which refer to the 
programme goals that are being evaluated. Without these stated goals, evaluating a service or 
programme is futile, since a comparison between action and its impact cannot be derived. In 
order to ultimately improve the quality of health care, evaluation research aims to measure and 
improve the various components that will guide movement in the direction of achieving this. In 
order to make service quality assessments most effective, the information that it elicits should be 
used to analyse, interpret, feedback and plan remedial actions (AKF, 1993) which then in turn is 
re-assessed. 
 
2.3 Programme Effectiveness 
The concept of “programme effectiveness” also relies heavily on process evaluation principles. 
Knippenberg (1986) suggests that programme managers are often faced with situations where it 
would be desirable to measure the impact (such as reduced numbers of babies born with HIV) 
but that this may be too difficult or expensive to do. In this scenario he advocates that 
programme managers should at least measure the conditions for a programme to be effective. In 
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other words, Knippenberg suggests that if a programme is well designed, then effectiveness (and 
impact) can be assumed if a set of conditions are met. He has put forward six „conditions of 
programme effectiveness framework‟ which, in addition to access, cover processes: availability 
of key resources, capacity, initial use of the service, quality of care and continuity of care. 
UNICEF and WHO have used this approach to evaluate PMTCT in low and middle income 
countries (2001).  
 
In the literature the PMTCT programme‟s effectiveness has also been tracked by using coverage 
indicators, such as what proportion of the infected mothers had access to ART and care and what 
proportion of HIV exposed infants have access to ART, HIV testing and appropriate referrals 
(Stringer, Chi, Chintu, Creek, Ekouevi, Coetzee, Tih, Boulle, Dabis, Shaffer, Wilfert & Stringer, 
2008). Stringer et al (2008) further state that in order to ensure coverage, the complete sequence 
of events must be in place and delivered for prophylaxis to be delivered. This critical pathway is 
made up of process indicators that are collected routinely from facilities as part of the PMTCT 
programme reporting. Client fall-out along this critical pathway can also be significant, with 
mothers falling out after HIV testing and then not accessing ART; or HIV exposed infants not 
returning for HIV testing following all interventions within the antenatal, labour and postnatal 
periods. Although the aforementioned evidence exists with regards to which proportions of 
women and infants access care, the literature search does not produce reasons as to why women 
did not access care or why they dropped off along the care pathway (Stringer et al, 2008). 
 
2.4 Research process of Developing a Tool 
Various scientific articles published on health-instrument or tool development and validation 
make reference to “A Guide for Instrument Development and Validation” by Benson & Clark 
(1982). For example, Boyce, Gowland, Hardy, Rosenbaum, Lane, Flews, Goldsmith and Russel 
(1991) used this guide for the development of a quality of movement measure for children with 
cerebral palsy. The development of the short musculoskeletal function assessment questionnaire 
with regards to validity, reliability and responsiveness was based on Benson and Clarks guide 
(Swintokowski, Engelberg, Martin & Agel, 1999). Zarc, Pawlowski, Allen, Bryant-Stephens, 
Winston, Angusco and Shea (2006) developed and validated a tool to measure asthma symptom 
control in children using Benson and Clarks guide. 
 
 
 
 
 Page 11 
 
 
The guide depicts a 4 phase step by step (13 steps) guide to health-related tool development and 
validation. The 4 phases according to Benson & Clark (1982) are as follows: 
 Planning (Steps 1-2) – this includes defining the content area that will be measured and 
the target group for which the tool is intended.  
During the planning phase the literature is reviewed to ensure that an appropriate, reliable 
and valid tool does not already exist. Out of this phase, the key concepts for item 
generation are developed and open-ended questions are presented to the judges.  
 Construction (Steps 3-6) – the objectives of the tool that define the purpose of the tool 
will be stated. The objectives will lend itself to preparing the table of specifications, 
which are two-way grids reflecting content areas and categories. Item writing follows and 
the process ultimately intends on linking items to set objectives. A flow chart is then 
developed which defines each step in the process. This is followed by defining the format 
for responses, e.g. ranging from “strongly agree” to “strongly disagree”; or “Yes”, “No” 
and “N/A” (Not Applicable). Once all items and objectives have been linked and 
consensus is reached with the judges (experts in health), content validation has been 
achieved.  
 Quantitative Evaluation (Steps 7-11) - validity and reliability, through quantitative 
evaluation of the tool is conducted during the piloting phases. Estimating the reliability of 
the tool, will follow through field work with 2 sets of observers who will apply the tool 
within the same settings and use the same clients, so that the findings can be compared. 
The group of testers will be allowed an opportunity to feedback on the experiences with 
regards to applying the tool, so that ease of use can be determined  
 Validation (Steps 12-13) – validation of a newly developed tool may be an ongoing 
process which requires ongoing research efforts and may not be concluded in one 
research paper. Validation is essential because it allows one to be confident with regards 
to what the tool is actually measuring (Benson & Clark, 1982: 798).   
As part of the validation process, the study sample will be calculated so that it is 
representative of the study population. This will facilitate the process of comparing 
routine data with information that is found within the registers and folders of the study 
sample. 
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2.5 Available PMTCT tools  
The further review of existing literature aimed at determining whether a checklist or assessment 
tool already exists, that would help to elicit the information required with regards to the quality 
of the PMTCT service that is rendered to the HIV exposed infant within the PHC setting. Based 
on this, the need for further development of such a tool would be determined.  
 
A literature search was conducted using the following key words: PMTCT, Assessment Tool, 
Evaluation, Quality of Care, Effectiveness of PMTCT programme and Development Validation 
Tool. This search yielded a set of tools that have been used to evaluate certain aspects of the 
PMTCT programme and services.  
 
The following 10 tools were produced out of this process and are described in Appendix A: 
- Labour Ward Monthly Data Summary and Antenatal Data Validation Tool (Smit, in 
press) 
- Module 9 PMTCT Programme Monitoring Tool for Antenatal Care and Maternity Ward 
Register Tool (CDC, n.d.) 
- Western Cape Provincial PMTCT Checklist (WCDoH, 2008) 
- Volunteers Follow-up Schedule for Expectant Mothers on Highly Active Antiretroviral 
Treatment (HAART) and Volunteers Follow-up Schedule for Expectant Mothers on 
PMTCT (Kroon, 2011) 
- Family Health International (FHI) Institute for HIV/AIDS (2003) published a health 
manager‟s toolkit called, Baseline Assessment Tools for PMTCT of HIV  
- Evaluation of the Scale up of the PMTCT Infant feeding Counselling Training 
Programme in Tanzania (Luceno et al, 2010) 
- PMTCT Folder Review of Antenatal Services - Integrated HAST audit Tool and PMTCT 
Folder Review of Labour Ward - Integrated HAST audit Tool (WCDoH, CoCT & UWC, 
unpublished) 
 
Of the ten tools, eight are applicable to the primary care setting, four of which focus on the 
hospital setting as well. The tools focus predominantly on the labour ward and antenatal setting 
and make use of the registers and interviews in order to gain the information required.  
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Although most of the tools focus in some way on the elements of the PMTCT programme that 
are rendered to the HIV exposed infant. Two of these three 3 tools are applicable to the 
community setting (rather than the facility setting) for use by community field workers and the 
source of information is through conducting interviews and support visits. The third tool focuses 
on the HIV exposed infant and is applicable to the primary care setting. It has been used by 
PMTCT and project managers and the information is gathered through interviews. The focus of 
this tool is predominantly on protocol and drug availability, infant feeding counselling questions 
aimed at the facility staff and staff competency in rendering the PMTCT service to the infant. 
This tool does not focus on the infant folder or PMTCT register in order to verify that the 
PMTCT programme is implemented according to policy. It will therefore not be possible to 
adapt this tool for the SA context. It is thus evident that a tool that will focus specifically on the 
quality of the PMTCT programme that is rendered to the HIV exposed infant in the primary 
setting is needed and will add value within the framework of process evaluation.  
 
There are also tools that have been developed in various quality improvement initiatives, such as 
the 3 interview questionnaires used in the study conducted in improving the coverage of the 
PMTCT programme through a participatory quality improvement intervention (Doherty, Chopra, 
Nsibande & Mngoma, 2009) and the tools used to conduct interviews in the study on an 
evaluation of PMTCT implementation and integration into routine maternal, child and women‟s 
health services (Horwood etal, 2010). However for the purpose of this study, the inquiry was 
limited to tools used to evaluate the quality of the actual PMTCT service rendered to the HIV 
exposed infant.  
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CHAPTER 3:  METHODOLOGY 
 
3.1 Introduction 
A predominantly qualitative strategy was used, since this study was aimed at developing the tool 
through acquiring the input and experiences of experts in the field of HIV and AIDS within the 
Western Cape Province. This facilitated a process of understanding (Katzenellenbogen et al, 
1997) what experts in the field required to be included in the tool. 
 
3.2 AIM 
To develop a tool that would measure the quality of care of HIV exposed infants in the PMTCT 
programme in the primary care facility setting in South Africa. 
 
3.2.1 OBJECTIVES 
 To engage local programme managers in a participatory process to develop a tool that is 
locally applicable and relevant, and that captures local management expertise 
 To identify the evaluation domains required to measure quality of care of HIV exposed 
infants in the PMTCT services at primary care level 
 To develop an indicator set for each evaluation domain 
 To conduct a small pilot of the tool to assess its feasibility and the usefulness of the 
information generated 
 
3.3 Study Design 
Participatory Research (PR) was the study design that was applied. According to Breitbart (2003, 
161) “Participatory Research seeks to democratise research design by studying an issue or 
phenomenon with the full engagement of those affected by it”. The focus was on collaboration 
with regards to developing the research agendas and designing actions that would ultimately 
improve the outcomes of care rendered to the HIV exposed infant. This type of research is 
increasingly being used in health research (Cornwall & Jewkes, 1995) and it in essence breaks 
the mould of conventional research and focuses on the process of sequential reflection and 
action. In this research, the action was the development of the tool.  Local knowledge of 
 
 
 
 
 Page 15 
 
programme experts or those managing the health services formed the basis of the research and 
planning. This study design suited all four phases of tool development and validation (Benson & 
Clark, 1982) most appropriately.  
 
As stated by Baum et al (2006) the researcher and participants developed a blurred line between 
them, as the power was deliberately abdicated by the researcher within the relationship. During 
the sessions, the researcher allowed all opinions of the HAST experts to be expressed and did not 
steer the discussion in any particular direction, i.e. the researcher posed questions and 
deliberately allowed the discussions to flow. Therefore, for this study the experts in the HAST 
field played an active role in deciding on the content of the tool, the piloting thereof and the 
appraisal of the tool. Although this was very time-consuming, the experts were involved 
throughout the entire cycle of tool development. The managers of the health services were 
involved in the piloting and refinement of the tool. 
 
The process of tool design was built on the approach suggested by Benson & Clark (1982) as 
described in the literature review and the tool content was informed by what others had already 
done in developing a tool of this nature, but with the intent of addressing the context specific 
requirements in the Western Cape. Broadly the process of tool development consisted of: 
- Planning: Panel discussion with experts to reflect on the existing Integrated HAST audit 
tool, the steps taken to develop it and the gaps that exist within it. The target audience 
and populations, as well as the domains were defined. 
- Construction: The purpose of the tool was defined, a draft tool with indicators was 
developed over 2 sessions with the HAST experts, so as to gain a degree of content 
validation. 
- Quantitative evaluation: A small pilot was done by one of the HAST experts to achieve a 
greater sense of whether the content was valid and reliable. Revision of the tool with the 
panel of HAST experts done to further refine the indicators. A second pilot was 
conducted by a broader team including facility staff, their supervisors and HAST experts 
to determine validity and reliability of the tool. 
- Validation: This is an ongoing process. The write up of the thesis contributes to this 
process. The tool will be used widely as part of application of the Integrated HAST audit 
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tool on an annual basis throughout the WCP. The provincial integrated HAST audit tool 
task team will remain responsible for further reviewing and refining of the PMTCT Baby 
tool along with all other tools.  
 
Throughout this process of tool development, diversity of views was revealed and opportunities 
presented, that required further exploring (UWC, 2002).  
 
Diagram 3.1: Methodological process flow for this study 
 
Research activities Steps of tool development 
Phases of tool 
development 
Preparation:  
Researcher 
Step 1: Select the HAST experts: core task team 
members and implementers 
Planning Step 2: Define role of session facilitator 
Session 1: 
Core task team 
Step 3: Reflect on the Integrated HAST audit tool 
with the core task team members  
Step 4: Define the purpose of the tool, the target 
audience and target population 
Construction 
Step 5: Define the domains for the Integrated HAST 
audit tool  
Step 6: Develop the indicators for the PMTCT Baby 
Tool 
Session 2 and 3: 
Core task team 
Step 7: Present the review of the current PMTCT 
tools that were identified in the literature review 
Step 8: Develop draft indicator set and sampling 
and present draft 1 of the PMTCT Baby tool 
Step 9: Core task team to comment on tool and draft 
2 of the PMTCT Baby tool 
Pilot 1: 
One core task team 
member 
Step 10: Conduct first pilot at Langa and Wynberg 
clinics, to test 
Quantitative 
Evaluation 
 
Session 4: 
Core task team  
Step 11: Feedback from pilot to evaluate tracer 
indicators 
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Session 4: 
Core task team 
Step 12: Refine data collection tools 
Quantitative 
Evaluation 
 
Step 13: Draft 3 of tool developed and planning for 
second pilot of tool with implementers 
Pilot 2: 
Core task team and 
implementers 
Step 14: Conduct training for second pilot 
Step 15: Second Pilot the tool 
Feedback workshop: 
Core task team and 
implementers 
Step 16: Results collated and presented to core task 
team and implementers at feedback session 
Step 17: Determine feasibility and usefulness of this 
tool. 
Validation 
Step 18: Finalise the PMTCT Baby tool 
 
3.4  Selection of the HAST Experts  
Two groups of HAST experts were involved in this process, i.e. the core task team and the 
implementers. The core task team were involved in all the phases of the actual development of 
the tool and the implementers were involved in the second piloting and feedback sessions. 
 
For the core task team, experts within the HAST arena within both local and provincial health 
authorities, HAST Non-Profit Organisation (NPO) partners and public health academics were 
invited to participate according to the criterion sampling strategy (Rice & Ezzy, 1999).  For this 
study the following criteria was applied:  
 Individuals actively working within the HAST arena within the WCP for at least 5 years. 
 Individuals previously involved in the development and application of the Integrated 
HAST audit Tool within the WCP. 
 Individuals of a diverse opinion. The experts represented HAST health service delivery 
within the provincial government and local authority settings, public health academic 
arena and HAST health programmes within both provincial and local government 
settings. 
 Individuals involved in managing and coordinating HAST programmes or in researching 
the management of HAST programmes. 
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Within the WCP, a quarterly meeting exists where the Integrated HAST audit tool is discussed 
with regards to its current state, relevance to the services, alignment with dynamic protocol and 
policy. At this meeting amendments to the Integrated HAST audit tool are made if required. All 
the members who attend this forum met the criteria to be core task team members. Although ten 
core task team experts were invited to participate in the development of this tool, of these, seven 
individuals participated in all the sessions and the remaining three were able to attend on an 
adhoc basis when their schedules permitted. 
 
The selected core task team who had met the specified criteria represented the HAST arena 
within the WCP as follows: 
 2 District HAST Coordinators working within the MDHS, 
 1 HAST Clinician and Programme Support Medical Officer from the CoCT, 
 2 HAST experts and consultants to the HAST programme within the WCP, from the 
Desmond Tutu TB Centre [NPO] focussing on PMTCT system strengthening,  
 2 HAST programme managers from the CoCT, 
 1 Provincial DoH HAST programme manager,  
 1 Comprehensive Health Programme manager from the MDHS and  
 1 Academic from the School of Public health at the University of the Western Cape.  
 
The second group of experts were the implementers and were defined as health staff within the 
HAST service delivery arena within both local and provincial health authorities. The following 
criterion sampling strategy (Rice & Ezzy, 1999) was used:  
 Individuals active within the HAST service delivery arena within the WCP for at least 2 
years. 
 Individuals previously involved in the application of the Integrated HAST audit tools 
when auditing other HAST programmes.  
 Individuals involved in rendering and supervising HAST service delivery. 
 Individuals were facility staff willing to have their facilities participate in the pilot, or 
were the supervisors of these facilities 
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Seven implementers were purposefully selected to give input into the structure and content of the 
tool during the training and pilot phase. The selected seven implementers were as follows: 
 2 facility managers of the two sites who met the criteria for piloting and indicated their 
willingness to have their facilities included in said pilot. The two selected sites were 
based on being a low burden clinic with no ART services and a high burden clinic with 
an ART service on site, 
 2 of the professional nurses who render PMTCT services within the selected facilities,  
 1 PMTCT coordinator for the sub-structure and 
 2 PHC managers for the geographical area where the piloting would take place.  
 
3.5 Ethics  
Participation of the HAST experts, PMTCT coordinators, facility managers, supervisors and 
facility staff in this research process was completely voluntary. Each of the participants provided 
informed consent and was informed that he or she could withdraw from this study at any time 
during the process. Every effort was made to respect the dignity of each of the participants, by 
allowing them to express their opinion and not allow any one member to dominate a discussion 
or refute another‟s opinion. The time away from their workplace did not exceed 3 hours per 
session or per pilot, with the exception of the training session, which took the participants out of 
their workplace for 5 hours. The impact on the time of the core task team members was mitigated 
by the fact that they were mandated to conduct monitoring and evaluation and ensure quality as 
part of their core function. 
 
The development of this tool provided programme and facility managers with a tool to  improve 
the quality of the PMTCT service rendered to the HIV exposed infant which not only measured 
what they achieved against expected standards, but which also sets clear standards and was 
aligned to the policy. The development and piloting of this tool took place at no cost to the 
WCDoH and local government health authorities, other than staff time as described above. 
 
There was no breach of confidentiality since the names of mothers and infants did not form part 
of the data that was collected. None of the patient folders or registers were removed from the 
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facilities. All participants involved in the piloting of the tool were reminded that professional 
secrecy was to be maintained and this was adhered to.  
 
Higher Degrees Research Committee at the University of the Western Cape provided procedural 
ethics for this research. 
 
3.6  Role of group / session facilitator 
The sessions were facilitated by the researcher to ensure that all participants had an equal 
opportunity to express their opinions. One of the researcher‟s main tasks was to ensure that no 
one member dominated any of the discussions. Other tasks included note taking, voice 
recordings and clarifying that the core task team contributions were correctly understood and 
captured for the purpose of this research and further development of the tool.  
 
3.7 Development of the Baby PMTCT Tool   
The core task team contributed to the development of the tool from planning through to indicator 
construction, the training and the two rounds of piloting. The implementers contributed to the 
second pilot and the assessment of feasibility, validity and usefulness of the tool. All decisions 
with regards to inclusions in the tool were by discussion, debate and ultimately reaching 
consensus. 
 
3.7.1 Session 1 
The purpose of session one was firstly to reflect on the content of the existing Integrated HAST 
audit tool to inform the decision on whether it would be necessary to develop a new component 
(to be called the PMTCT Baby tool) to evaluate the service rendered in the HIV exposed infant 
on the PMTCT programme until the 6 week HIV PCR test has been conducted and in terms of 
feeding choices for the entire period that the infant was in care.  Secondly, the purpose was to 
reflect on the structure of the existing Integrated HAST audit tool to decide whether this was 
suitable for the new component. 
 
 
 
 
 
 
 
 Page 21 
 
Review of current Integrated HAST audit Tool 
In order to make the afore-mentioned key decisions, the core task team needed to be familiarised 
with the content and structure of the Integrated HAST audit tool. This tool is a management tool 
consisting of evaluation domains and programme components. The nine evaluation domains are 
contained within the matrix, consisting of 152 indicators covering the following HAST 
programme components: HCT, HIV Care, STI, TB, ARV Care, PMTCT antenatal HCT and HIV 
Care and PMTCT labour ward and immediate post natal care.  
 
Table 3.1: Structure of current tool showing evaluation domains and programme components  
 
General TB  STI  HCT  
HIV 
Care 
ARV 
Care 
PMTCT 
antenatal 
HCT and 
HIV Care 
PMTCT 
Labour 
ward 
Access 
        
Availability 
        
Capacity: Staffing 
        
Capacity: Systems 
        
Capacity: 
Management          
Quality 
        
Integration 
        
Continuity of 
Care         
Outcome 
        
 
This table depicts the matrix that serves as a management tool. The columns in the tool 
represents the HAST programme components that are being evaluated and each of the rows 
reflect the evaluation domains, i.e. the conditions of effectiveness. In each cell there is then a set 
of tracer indicators (not shown here) to evaluate the domain for each of the HAST programme 
components.  
 
It was noted that the existing tool already evaluates PMTCT care given in the antenatal setting 
with regards to HCT and HIV care and in the labour ward with regards to intra-partum and 
immediate post-partum care to the mother and infant. The indicators related to this are shown in 
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Table 1.2.  The core task team decided that it was necessary to develop a Baby PMTCT Tool to 
evaluate care given to the HIV exposed infant when he or she is registered at the local primary 
care facility for on-going prophylactic care until an HIV PCR is conducted at 6 weeks of age and 
in terms of infant feeding and on-going care thereafter. It was decided that existing Integrated 
HAST audit tool would be utilised as a template for the development of the new tool and in 
particular that the same evaluation domains and criteria for the selection of tracer indicators 
would be used. 
 
Table 3.2: Existing PMTCT indicators included in the Integrated HAST Audit tool 
 
PMTCT Antenatal HCT and 
HIV Care 
PMTCT Labour ward  
Access 
Early bookings (<20weeks) - 
HCT uptake - 
Availability - - 
Capacity: Staffing 
Clinical staff trained in 
HIV/AIDS clinical training 
Clinical staff trained in 
HIV/AIDS clinical training 
Capacity: Systems Antenatal folders retrievable - 
Capacity: Management  - - 
Quality 
Counselling form used Standard HIV/ART  stationery 
Consent taken EDD recorded 
Risk reduction discussed Received NVP in labour  
Received adequate AZT 
antenatally  
Received ART regimen in labour 
Condom issued Condoms issued 
Feeding options discussed Delivery protocol followed 
RPR done and results noted 
Baby received ART regime at 
delivery and discharge 
Weight, BP, urinalysis done - 
Correct data transfer; folder to 
Antenatal HCT register 
Correct data transfer, folder to 
labour ward register 
Integration 
Symptomatic TB screen Contraception on discharge 
Symptomatic STI screen - 
Continuity of Care On-going counselling 
Appropriate HAART 
commencement / referral (folder 
review) 
Outcome - - 
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The core task team noted that the Integrated HAST audit was accompanied by a manual as well 
as a data capturing template in Excel format which automatically generates graphs, allowing for 
easy feedback to service providers and programme implementers. The Integrated HAST audit 
has developed a feedback process which takes place in a structured manner. Each facility has to 
select 3 actions or areas for improvement within each programme area and formulate action 
plans. During the following audit, which is conducted 6 months later, these action plans are 
revisited in order to determine whether any improvements have taken place or not. (Own 
experience of the sequence of events, having been employed in the Child Health & HAST 
programmes within the MDHS from 2002 – 2010). The core task team decided to recommend 
this same process be used in giving feedback to facilities on the results of the PMTCT Baby tool. 
 
Review of current data collection tools 
Time was taken to reflect on these data collection tools and particular attention was given to how 
sampling was done in the various folder reviews (inclusive of paper based registers). The data 
collection tools are: the routine health information sheet, a facility manager‟s questionnaire, the 
consulting and counselling room observation from and the series of folder reviews. The folders 
reviews address the following programmes within HAST: 
- HIV Counselling and Testing, 
- HIV General Care, 
- STI, 
- TB, 
- ARV Care, 
- PMTCT Antenatal HCT and HIV care and 
- PMTCT Labour Ward and Postnatal HIV Care (WCDoH, CoCT & UWC, in press). 
Annexures to the data collection tools include a list to collate the different training courses that 
the staff had attended and a folder sampling form for each of the folder reviews, to record the 
folders had been accessed as well as those sampled but not found.  
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It was decided that a new folder review for the HIV exposed infant would be added and that an 
amendment to the facility manager questionnaire would be made in terms of the ART drug and 
consumable availability for the PMTCT programme. 
Purpose of the tool: 
It was agreed that the purpose of the tool was to evaluate both the routine PMTCT data and the 
care provided by the staff within the health facilities to the HIV exposed infant who registered 
for PMTCT services. The evaluation would be for the period commencing at the time that the 
infant is registered at the public health clinic until the 6 week HIV PCR test is conducted and 
following that with regards to infant feeding and continuity of care, for the sampling period not 
exceeding 6 months in age. It was agreed that the development of the PMTCT Baby tool was 
indeed required to dovetail with the current Integrated HAST audit tool.  
 
Target audience 
The user of this tool was defined as being the middle level health managers, who would be 
equipped with adequate information to facilitate decision-making, determine programme 
effectiveness and promote programme improvement at facility level. The middle level health 
managers would include the Provincial HAST Coordinators, District / Sub-Structure and sub-
district level HAST co-ordinators, Facility Managers and other facility level staff, PHC 
Managers and other programme coordinators / managers.  
 
Target population  
The target population has been defined as the HIV exposed infants who are enrolled onto the 
PMTCT programme, irrespective of whether or not the mother had received antenatal or intra-
partum ART. These infants would be assessed from date of registration at the clinic, until an HIV 
PCR is conducted at 6 weeks and beyond that for the sampling period, not exceeding 6 months of 
age. 
 
In the event of infants testing PCR positive or negative after being on the PMTCT programme, 
the tool would allow one to track whether or not the PMTCT policy was adhered for the mother 
and infant and thus determine the level of programme effectiveness. 
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Domains for the Integrated HAST audit tool 
For the Integrated HAST audit tool to be effective, a monitoring and evaluation framework was 
developed. In order for a programme to be effective, a set of critical conditions had to be met 
within this framework.  
 
During the development of the Integrated HAST Audit tool, evaluation domains were agreed 
upon and at this session, the current domains were presented, discussed and re-assessed with 
regards to its relevance for the PMTCT Baby tool. The domains presented were as follows:  
 
Table: 3.3. Domains for the Integrated HAST audit Tool  
 Access to the programme must be ensured 
- Availability of key resources and capacity to conduct the programme 
- Continuity of Care is a key issue to ensure that the care pathway for the client is 
seamless and maintained 
- Quality of care provided is the major element of final effectiveness of the intervention. 
Adherence to standard protocols and procedures must be in place and have to be 
followed. 
- Integration of Services increases access across the HIV/TB/STI cluster and can be seen 
as part of a holistic approach to the client. This domain is essentially an aspect of quality 
of care, but has been separated from that domain so as to provide managers with an 
integration lens 
Source: (Scott et al, 2010) 
 
The core task team agreed that the same set of domains would be applicable, against which the 
indicators for the PMTCT Baby tool would be based.   
 
Selection Criteria for the Tracer Indicators for the PMTCT Baby Tool 
Based on the fact that selection criteria for the tracer indicators have previously been established 
with the development of the Integrated HAST audit tool (Scott et al, 2010), it was decided that 
these criteria would be applied for the selection of the tracer indicators for the PMTCT Baby 
tool. The criteria adopted for this tool has been modified from Scott et al (2010): 
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- Measure similar implementation aspects to a set of programme elements so that, by 
measuring the tracer, it is possible to deduce the performance of the other elements 
- Be an essential part of the programme.  
- Be realistic in relation to current best practice in the HIV and TB programmes. 
- As far as possible, align to National and Provincial guidelines. 
- Be possible to measure in a valid, reliable and interpretable way. 
- Provide information that one can use to improve the management of HIV/TB/STI 
programmes at sub-district, district and provincial level. 
- Preference is given to indicators that can be drawn from current routine monitoring 
systems or that can be incorporated into such systems without undue burden to staff 
involved in the collection of routine data. 
 
This session ended with a decision that the researcher would draft a set of indicators which 
would set the basis for the data collection tool that would dovetail the Integrated HAST audit 
tool and that it would align to the 5 domains and the criteria for the selection of the tracer 
indicators. This first draft would be distributed for comment to the core task team and would take 
discussion at the next session. 
 
3.7.2 SESSION 2 and 3: Discussion of sampling techniques and tracer indicators  
 
Review of PMTCT Tools identified during the Literature Review  
The literature review which had been conducted by the researcher was tabled and reviewed by 
the group at session 2. It was then unanimously agreed that all available tools were not suitable 
to be utilised as the PMTCT Baby tool. The domains used with the tools that were found in the 
literature review were not compatible with those that were required for this tool. The indicators 
used were either not applicable or already part of the PMTCT indicators contained in the 
antenatal and intra-partum folder reviews in the Integrated HAST audit tool.   
See appendix A for detail on the tools that were found during the literature search.  
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Review of draft indicator set and sampling 
Draft 1 (appendix B) of the PMTCT Baby tool that had been compiled and distributed for 
comment to the HAST experts after session 1 formed the basis for further discussion in session 2 
and 3. In this section of the write up of the research process, the discussion on sampling of 
folders is described as well as the discussion on a small subset of the indicators.  Not all the 
discussions are reported here as there was considerable overlap in issues relevant to each 
indicator. The subset of discussions have been chosen to illustrate how the core task team 
debated together the relevance, feasibility and validity of the indicators. 
 
Sampling  
Although the process of developing this tool was a predominantly qualitative study, the tool 
itself was a quantitative tool. For the folder review it was of value to identify the distribution of 
quality of care, but since ten folders were too small a number to provide reliable results (the 95% 
confidence intervals are very large), the intention was to identify main problems that may exist. 
 
Since the PMTCT programme had been designed to keep the HIV exposed infant HIV negative 
at 6 weeks PCR testing, it was decided that folders of 5 infants who tested HIV PCR positive and 
5 who tested HIV PCR negative would be required per facility. The selection of folders (infants) 
was retrospective since this would allow the opportunity to track whether there was an 
association between adherence to protocol and the HIV PCR result, i.e. the outcome. 
   
Following discussion with regards to the most appropriate time to commence sampling, it was 
decided that for this evaluation, it would be adequate to commence sampling 3 months prior to 
the audit date in order to access recent folders. This would mean that the infant was registered 
onto the programme 3 months ago and had received care according to the PMTCT policy for at 
least 3 months. The infants of mothers, who had refused HIV PCR testing, would be excluded 
from the sampling. The core task team agreed on the exclusion since it would be fruitless 
tracking programme effectiveness without a programmatic outcome. The tracer indicator 
“Proportion of folder found” was agreed to by the core task team members and it was agreed that 
since this indicator determines the availability of sampled folders, that it would reside within the 
availability and capacity domain. 
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The PMTCT register would be used to select the sample of infant‟s folders. In the session there 
was a further debate on whether folders of the HIV positive mothers of the selected infants 
should be drawn and reviewed. It was decided that information related to the mothers HIV care 
would be included, since care to the mother can influence the HIV PCR result of the infant in a 
positive or negative manner, as follows: 
- The WHO staging and CD4 count of the mother would reflect the mother‟s clinical state 
during the antenatal and breastfeeding period and thus have a positive or negative bearing 
on the HIV PCR result of the infant 
- Inappropriate or inadequate management plan in terms of HIV care or ART in 
accordance with clinical guidelines, could negatively impact the infants outcomes. 
- Poor continuity of care for the mother would negatively impact the outcome for the 
infant, but also affect that the chances of survival of the mother  
Since this information on the mother, which ties into infant care, was not always accessible in the 
PMTCT baby register, it was agreed that the mother‟s folder should be retrieved in order to 
access this. It was also deemed opportune to look at another aspect of the PMCTC programme 
which is not strictly postnatal care but relevant to the longer-term well-being of the infant, i.e. 
whether the mother accesses on-going care or not. In conclusion, the folders of all the mothers of 
the sampled infants would be retrieved for evaluation, irrespective of the infants HIV PCR 
outcome.      
 
Some of the challenges that were raised in terms of sampling included were as follows: 
- In a setting where the burden of HIV exposed infants is very low, there would be 
challenges in obtaining the sample size of 10 folders when applying the suggested 
sampling frame.  
- In facilities with low MTCT rates, finding 5 sequential HIV PCR positive folders may 
span across 1 – 3 years and 5 sequential PCR negative folders may span across a few 
months or even weeks.  
In these circumstances, another dynamic is introduced of evaluating different staff (as they often 
rotate) over a long period of time, resulting in the two groups of infants (those who test positive 
and those who test negative) not being properly comparable. The Integrated HAST audits are 
conducted as often as 6 monthly, with the focus on recent change after action plans had been put 
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in place for improvement. Since the agreed sampling in the afore-mentioned circumstances 
would pre-date any of the agreed interventions, the core task team agreed to re-visit sampling. 
During session three, the routine data set for the PMTCT programme was tabled and discussed 
and a very good example was raised by one of the core task team members. The data for the 
Klipfontein sub-district for the previous 6 months revealed none of the infants registered on the 
PMTCT programme at any of the sites, had tested HIV PCR positive. It was noted that this sub-
district has the second highest number of infants registered on the PMTCT Baby register in the 
entire WCP.  The concern was heightened that we may not obtain any HIV PCR positive infants 
in the sampling period. 
 
The core task team then further deliberated options on whether to use 5 folders of HIV PCR 
positive infants in the prior 6 months and then an additional 10 HIV PCR negative folders. The 
rationale was based on the fact that 5 HIV PCR folders may not be available for sampling within 
the sampling period, but that a greater chance existed with obtaining the HIV PCR negative 
folders for the specified sampling period.   
 
Towards the end of discussions on sampling in session three, the core task team questioned 
whether it would make a difference whether the baby was HIV PCR positive or negative and 
whether the focus should not just remain on the quality of care that the baby received at the 
facility in terms of PMTCT programme. In essence, whether we should use 10 folders 
irrespective of PCR result? 
 
After all of the afore-mentioned deliberation, the core task team decided as follows: 
- Since the aim of the tool is to evaluate the quality of the PMTCT programme offered to 
HIV exposed infants and their mothers, the PCR result would not be taken into account 
when sampling the 10 folders.  
- The number of infants on the PMTCT register would depict the sampling sequence used, 
starting on a date 3 months ago, select the infants as follows for all infants who had an 
HIV PCR done:  
i) <100 PMTCT babies / year – then select 10 sequential folders;  
ii) 101 – 300 babies / year – select consecutive folders;  
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iii) 301+ PMTCT babies / year – select every 5th PMTCT folder.  
- The folders of the mothers of the sampled infants would be selected to answer the 
questions that pertain to their postnatal HIV related care.  
 
Although the core task team agreed that it would be ideal to link the mother‟s folder to that of 
her infant in practices (i.e. one folder for both), they acknowledged that in most instances it 
would still remain difficult to find the mothers clinical information. This was predominantly due 
to the fact that ~50% of the facilities do not offer all HAST services and the mothers clinical 
information would often be at another facility where she may be accessing life-long ART. It was 
then concluded that a section be added to the sampling of the PMTCT Baby tool, where the user 
could state the number of mother folders found that did or did not meet the criteria to be included 
in this audit and the number of mother‟s folders that could not be found. In this instance the 
concern would however remain whether we could be sure that the mother is accessing HIV care 
or ART elsewhere. 
 
Counselling and Consent Form Used 
It is a Western Cape and National policy requirement that written consent is taken when 
conducting an HIV test. When it relates to children and infants, the parent or legal guardian must 
provide written consent for the HIV test.  
 
The “HIV Consent and Testing Record for Adults and Children” is the standardised recording 
form, for use within the WCP in all public health facilities and at all non-medical HIV testing 
sites that are funded by the public sector. This form is used for capturing client details, recording 
of written consent, post HIV test advice, screening for TB, STI, PMTCT and family planning 
and to track counselling across 3 follow-up sessions. Since this form provides prompts and 
guidance to its users, it essentially improves the quality of services delivery through ensuring 
alignment to policy when used accurately. The core task team felt it was reasonable to expect the 
use of this form to ensure quality through alignment to policy and to promote desired outcomes 
in practice. 
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Following significant discussion, the core task team agreed that the indicator “Proportion of 
clients counselling form used and consent taken” would be included in the Quality domain since 
it elicits adherence to policy, and that the following two questions should be included in the 
PMTCT Baby tool to gather the information for the indicator: 
- Has an HIV consent and testing form been used for the HIV PCR test? 
- Was consent taken for the HIV PCR test? 
 
The rational use of this as a tracer indicator was debated and tested against the selection criteria. 
The group agreed that as a tracer indicator it was able to deduce performance of other 
programme elements, i.e., screening for other HAST related conditions (TB, STI, PMTCT) 
ensuring the follow-up of clients after a positive HIV test result and facilitating integration e.g. 
access to contraceptives. This indicator was considered to be realistic and feasible since the 
information that is required to feed into the indicator, is easily derived from the form that is filed 
in the infants folder. It was also agreed that it was possible to measure this indicator in an 
interpretable manner. Managers and HAST programme coordinators would be able to use this 
information to identify gaps and respond accordingly in order to improve quality of service.  
 
Feeding practices discussed  
Feeding practices play a pivotal role when it comes to MTCT of HIV since transmission can 
occur through breast-feeding. Although this risk of transmission during the post-natal period is 
eliminated when the mother chooses to formula feed and is substantially reduced when the 
mother chooses to exclusively breast-feed, cultural pressures and various circumstances may 
cause the mother to mix-feed, which presents an opportunity for HIV transmission. Counselling 
clients about feeding practice is therefore important in reducing MTCT of HIV. The importance 
of this makes it imperative that feeding practices would be discussed at every visit in order to 
check that no mixed feeding takes place and to discuss current feeding practice and its related 
challenges.  
 
It was agreed that the indicator should be “Proportion of mothers with feeding practices 
discussed”. Initially the core task team agreed to include two questions i.e., “Is there a record that 
feeding options and mixed feeding were discussed at each visit” and “Was the full quota of 
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infant feeding formula issued with each visit”. With further discussion it was agreed that “each 
visit” should be changed to “last visit” since it would be a cumbersome process to go through the 
folder to access this information in events where the record-keeping was not reflected in the 
PMTCT register 
 
The domain Quality was selected since it was agreed that these questions elicit adherence to 
policy. Quality is ensured with adherence to policy or protocol. Responding to the identified gaps 
would improve quality of service and reduce the risk of MTCT through mixed feeding. 
 
Following deliberations, the core task team still agreed that the tracer indicator does not provide 
information that is required with regards to stock outs or non-availability of infant feeding 
formula (Pelargon or Melegi). The concern was that a stock out or non-availability of the 
formula could result in mixed feeding as well and not just the presence or absence of counselling 
on a monthly basis. We decided to add another tracer indicator to the facility manager‟s 
component of the Integrated HAST audit tool that would enquire into possible stock outs of the 
required formula feeding. The tracer “Proportion of facilities with stock outs of tracer drugs 
(ART) or consumables (infant feeding formula)” would reside under the domain availability and 
capacity.  
 
The tracer was measured against the criteria for selecting a tracer indicator and found that on a 
large scale it could measure the extent of stock out and possibly even the impact on PCR results. 
The required information is easily derived from the facility manager and can be confirmed on the 
bin card. Bin cards are expected to be in place for pharmaceutical and non-pharmaceuticals 
within all public health facilities. This information that the tracer indicator provides can be used 
by the PHC managers and facility manager to track ordering patterns and related gaps in these.   
 
PCR result available 
The HIV PCR result at 6 weeks of age is the measured outcome indicator that reflects the 
effectiveness of the antenatal, intra-partum and post-partum interventions in the PMTCT 
programme in the WCP. All efforts during the antenatal, intra-partum and post-partum period are 
in vain when the HIV PCR result is not known. It is this indicator that is tracked and reflects the 
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culmination of the PMTCT programme offered to that point. Both National and Provincial Policy 
define that a PCR must be taken at 6 weeks and it has been considered to be standard practice, so 
it is a realistic programme expectation.  
 
The core task team agreed that the tracer indicator would be, “Proportion of HIV PCR results 
available”. This tracer element was measured against the selection criteria for tracer indicators 
and it was agreed that since it was standard practice for the National Health Laboratory Services 
to send the results sheet to each facility and that it is standard practice that all laboratory 
investigation results are filed in the clients folders, it would not be unreasonable to expect to 
have the results available. A pre-requisite for the PMTCT programme is that the HIV PCR 
results are also recorded in the PMTCT Baby register, resulting in this indicator being considered 
realistic and feasible.  
 
The core task team decided on the question “Is the HIV PCR test result available in the folder”, 
since it was agreed that if no result exists, then an assumption could be made that the test was not 
done (as is the case with all record-keeping). If the HIV PCR test was done (at this or another 
facility), the expectation is that the result would be in the infants folder so that the appropriate 
future action can be taken. The laboratory HIV PCR result sheet should be in the infant‟s folder 
or result recorded in continuation notes in the folder or in a referral letter (if the HIV PCR was 
conducted at another facility).  
 
The quality domain was selected, since this question elicits adherence to policy which ensures 
quality and is a critical part of the PMTCT programme since it has a direct link with the outcome 
measure of the programme.  
 
Infant fully immunised 
The Expanded Programme on Immunisations (EPI) is the National and Provincial policy which 
guides the immunisation schedule. A fully immunised infant has a significantly reduced risk of 
contracting communicable diseases and access to immunisation reflects whether the infant has 
received comprehensive care. There is data to show that full immunisation will reduce under 5 
mortality rates by 15%: 13% as a result of Pneumonia and 2% as a result of TB (Groenewald, 
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Bradshaw, Msemburi, Neetheling, Matzopolous, Naledi, Daniels & Dombo, 2009). Infant and 
under 5 mortality rates in the WCP were confirmed at 21 and 26 per 1000 live births respectively 
in 2009 (Groenewald et al, 2009) and have been projected to be 19 and 26, 5 per 1000 live births 
respectively for the WCP (ASSA, 2008) in 2011.  
Since immunisations is standard practice, it was not considered to be an unrealistic expectation 
to have each infant immunised and immunisations is included within the routine monthly 
reporting of all public health facilities within WCP. Irrespective of the infants HIV PCR result, 
being fully immunised would be beneficial to any infant.   
 
The core task team agreed that the tracer indicator would be “Proportion of HIV exposed infants 
fully immunised”. The tracer indicator was measured against the selection criteria and found to 
be a proxy indicator for access to comprehensive health care, frequency of access to wellness 
services, but that it would in essence not be able to measure any other PMTCT related 
programme elements.  
 
The core task team decided on the question “did the baby receive the birth, 6 and 10 week 
immunisations as per schedule” to be included in this tool. The rationale for the schedule to 
include until 10 weeks only is due to the agreed sampling that commences 3 months ago, which 
would result in some infants not being eligible for the 14 week immunisations as yet. This 
information is easily found in the immunisation section of the “Paediatric Record” or in the 
continuation notes.  
 
This indicator resides within the Integration domain since it facilitates integration into the 
general or comprehensive service platform.  
 
Baby weighed at last visit 
The core task team deliberated on whether or not to include an indicator assessing whether the 
infant‟s weight was being checked and recorded and if so, how frequently this should be 
conducted. A decision was taken to go back into the PMTCT policy to identify whether a need 
for regular weight checks existed, other than for early detection of growth faltering. The PMTCT 
Policy stipulates that the dosage of the prophylactic drug prescribed (Nevirapine - NVP) should 
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be administered according to the weight of the infant and since most infants gain a significant 
amount of weight (enough to affect the dosage of NVP) during the first 6 weeks of life, the core 
task team agreed that the only way to ensure that an accurate NVP dose is calculated and 
adjusted, is by ensuring that the weight is checked and recorded.  
The tracer indicator “Proportion of infants with NVP supply checked and dosage adjusted” was 
first proposed but in the third session it was decided that the “Proportion of infants weighed at 
last visit”. Weighing the infant is not just current and expected practice within the PMTCT 
programme, but is also a standard of care provided to all infants, irrespective of the HIV 
exposure or HIV PCR status as it facilitates early detection of growth faltering. The information 
is retrievable from the continuation sheets in the infant‟s folders and is an indicator that will 
allow for quick wins when re-establishing poor performance of this indicator. Since this indicator 
again elicited the quality of care aligned to policy, it was placed under the quality domain 
 
Although the weight should be checked with every visit, the core task team agreed that to make 
the indicator feasible, evidence of a weight at the last visit recorded in the folder would be 
adequate. The question decided upon was, “Was the infant weighed and weight recorded at the 
last visit”.  
 
Discussion furthered on whether it would be expected for the mother to bring the balance of the 
baby‟s NVP along with each visit so that the difference in what is required could be issued. It 
was however decided that this would be of little value and was not considered essential to track. 
 
Appropriate management plan 
Should a medical condition be chronic or of a nature that requires regular visits to the health 
services, it is considered standard practice to document a management plan and to provide the 
client with a follow-up appointment. The core task team deliberated this issue extensively across 
session 2 and 3 and finally concluded that the indicator should be included and should in essence 
be deemed essential for both the infant and the mother.  
 
This indicator resides within the continuity of care domain, since on-going care would be 
promoted. The core task team decided on the tracer indicator, “Proportion of clients with future 
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management plan noted at last visit” and was measured against the selection criteria for tracer 
indicators and found that this indicator is essential and not nice-to-have as future management of 
the client would be compromised. The PMTCT policy expects that the infant and mother are 
followed up until such time that either are transferred to an ART or other appropriate site, or the 
infant is discharged when HIV PCR negative. The information required for this indicator is 
easily retrievable under the “Plan and Treatment” section of the HIV/ART visit summary form or 
it would be accessible within the clinical folder on the continuation sheets. This information 
would definitely improve the management of the client within the HAST programme in general 
and would provide management with information to identify gaps in care and to address them 
accordingly. 
 
The question decided upon “was an appropriate management plan noted at the last visits”. The 
rationale was that if any problems have been noted for either the mother or the infant, there must 
be a management plan recorded to further investigate, monitor or treat the problem. Should no 
new problems be noted, the management plan needs to record current treatment and dates for 
future visits. The management plan should also include a follow-up appointment date or time 
period (e.g. in 1 month).   
 
PMTCT Baby Register review 
The PMTCT baby register is an official document that is contained within the National and 
Provincial PMTCT policy. Although there is a slight variation between the expected data that is 
recorded in the WCP and National registers, the information that it yields produces all the 
Division of Revenue Act indicators that are required for reporting on a monthly basis to the 
NDoH and the Provincial Treasury. The core task team thus agreed that it is imperative that all 
the elements that are recorded in the PMTCT baby register are deemed as essential in order to 
make appropriate management decisions and to track progress towards closing the gaps that have 
been identified.   
 
The data that is recorded cover all aspects of post natal care within the PMTCT programme to 
the infant and the mother and it is the responsibility of all staff who record data in the register to 
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ensure that data integrity is maintained through accurate recording, ensuring that all fields are 
completed and that the data is aligned to that of the infant and mothers folder.  
Following discussions across the 2 sessions, the core task team agreed to two tracer elements as 
follows: 
- “Proportion of correct entries in PMTCT Baby register”: The measuring of this element 
would definitely deduce the performance of other programme elements related to the care 
of the infant within the PMTCT programme, i.e. frequency of visits to the facility, 
potential for mixed feeding, etc. This tracer indicator is important since it reveals various 
programme elements that management can respond to, based on the gaps identified, 
which will improve the rendering of services within the PMTCT programme.  
- “Proportion of HIV exposed infants whose mothers are registered in the PMTCT Baby 
Register”: This tracer indicator aims to measure the care offered to the HIV positive 
mother would either be of benefit to, or be detrimental to the HIV exposed infant. 
Ultimately this would ensure that the mother of the infant is appropriately managed 
according to the HAST policies and is aligned to Provincial policy. This is a realistic 
expectation and is current practice within the WCP.  
 
Both tracer indicators reside within the quality domain since adherence to the policy for the 
PMTCT programme is tracked which would reflect quality care was provided to the infant and 
the mother. It would also reflect that the Information Management Data Flow Policy (WCDoH, 
2009) was adhered to, since this commences with accuracy at the facility level before the data 
flows up to sub-district level, district, provincial and ultimately national level, would be 
dependent on this. 
 
The core task team then selected 3 questions that would be included in the PMTCT Baby tool, to 
evaluate the use of the register. The three questions and the rationale for the use of each of them 
were as follows: 
- “Is the 6 week PCR, test result, Cotrimoxazole at 6 weeks, initial and on-going feeding 
choice and provision of milk formula to date (where applicable) correctly entered from 
the clients folder into the PMTCT Baby Register?” 
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This question helps to assess the accuracy of the PMTCT Baby Register. Data from the 
PMTCT register is used to monitor programme performance and it is important that all 
the elements in the register correctly reflect information from the clinical records. The 
register should be used to ensure that the appropriate care has been provided.  
- “Does the mother of the infant have her PHC folder number recorded in the PMTCT 
Baby Register?” 
If the mothers PHC folder number is reflected it allows maternal and infant care to be 
linked more readily. Ideally, all PMTCT mothers should also have a folder at this facility. 
However, the folder number could also be from this or another facility, e.g. an ART site 
where the mother receives care. 
- “Does the mother of this infant have a CD4 result recorded in the PMTCT Baby 
Register?” 
Both a CD4 count and WHO Clinical Staging are required to determine the appropriate 
package of HIV care required by the mother. CD4 counts are monitored 6 monthly for the 
HIV positive clients not on ART and 12 monthly for those on ART. 
 
Mother identified as HIV positive in clinical notes 
A long standing struggle within the WCP according to the core task team of HAST experts, is 
that the PMTCT programme tracks and supports the infant until 6 weeks HIV PCR results, onto 
6 months after breastfeeding has ceased or the formula feeding is no longer issued as part of the 
programme. During that period appropriate referral of infants occurs and quality care for the 
infant becomes the focus, with little consideration for the care of the mother after child birth.  
 
The following concerns were expressed by the core task team: 
- these HIV positive women are accessing other health care services (family planning, TB 
screening, etc.) and the attending clinicians are often not aware of their HIV status; 
- that they breastfeed their infants exclusively with CD4 counts and WHO staging that is 
not tracked and the infant runs the risk of HIV transmission and  
- that all efforts are made to save the infant, who is then orphaned since the mother dies 
due to poor clinical care. 
 
 
 
 
 
 Page 39 
 
The tracer indicator “Proportion of mothers identified HIV positive in the clinical folder” was 
decided upon. It will measure that the mother is treated with the consideration that she is HIV 
positive and although this indicator cannot be routinely tracked, during the application of the tool 
the information is retrievable. The indicator will help to improve the provision of general HIV 
wellness care when acted upon by managers and supervisors. Since the HAST Programme at 
Provincial level have put stationery in place that must be used with each client who tests HIV 
positive, it is not unrealistic to expect that this indicator can be achieved. 
 
The core task team decided to add the question “Is the mother identified as HIV positive in the 
clinical folder” to the PMTCT Baby tool. It is expected that the mothers HIV status be indicated 
in continuation notes or that there is some indication of the mother accessing HIV care, e.g. use 
of the standard HIV/ART stationery or a CD4 count done and result recorded or filed.  
 
Standard HIV/ARV Clinical Stationery used 
It is a Western Cape and National policy requirement that the HIV / ART stationery is utilised 
with all clients on an HIV positive diagnosis in a public health facility. Irrespective of whether 
the clients is counselled and tested for HIV by the HIV counsellor or a clinical person, the 
HIV/ART stationery should be used with immediate effect.  
 
The use of the standard “HIV/ART stationery” improves the quality of services as it provides a 
prompt and guide to clinicians. The stationery facilitates recording and review of information, 
promoting continuity of care. If the mother receives ART elsewhere, it would be acceptable to 
not have complete records at the facility where the infant receives care. This form is used for 
capturing client details, WHO staging, CD4, social assessment, adherence to treatment 
counselling, clinical visits and explanatory notes. It comprises of an A3 white folded card called 
the “HIV/ART Patient Summary folder” and an A3 folded paper summary for clinical notes 
which allows for numerous follow-ups per sheet. Since this form provides prompts and guidance 
to its users, it essentially improves the quality of services delivery through ensuring alignment to 
policy when used accurately. It is thus realistic to expect the use of this form to ensure quality 
through alignment to policy and essentially to promote desired outcomes in practice. This form is 
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a crucial non-negotiable piece of stationery that must be used with all HIV positive clients 
irrespective of whether they are on ART or within general HIV wellness care. 
 
The core task team decided on the tracer indictor, “Proportion of HIV positive mothers with HIV 
/ ART stationery used”. The tracer indicator made it possible to deduce the performance of other 
programme elements, i.e. continuity of care for the HIV positive mother, access to counselling 
and clinical care. This indicator is considered to be realistic and feasible since the information 
that is required to feed into the indicator, is easily derived from the “HIV / ART stationery that is 
found in the clients folder. It was also agreed that it was possible to measure this indicator in an 
interpretable manner and that management would be able to use the information to make systems 
related decisions to improve quality of service. Since this indicator elicits adherence to policy, it 
was decided that it was best suited within the Quality domain. 
 
Following a brief discussion, the core task team decided to include the question: “has the 
standard HIV / ART stationery been used?”, to the PMTCT baby tool. 
 
Mothers CD4 count and WHO staging recorded 
According to the HIV Wellness and ART policy at National and Provincial level, both a CD4 
count and WHO clinical staging are required to determine the appropriate package of care to the 
client and should thus both form part of the baseline assessment for all HIV positive mothers. 
The WHO clinical stage should be updated when the new stage defining illnesses are noted and a 
CD4 count is required 6 monthly pre-ART, to assess disease progression and every 12 month for 
those on ART.  
 
The core task team decided on the tracer indicator “Proportion of HIV positive mothers WHO 
staged and CD4 count recorded” and agreed that it would also measure or indicate adequate 
access to HIV care. This information is easily accessible and measuring this indicator would 
allow management to respond to the gaps identified. Since this is current practice within the 
HAST programme in the WCP and on a national level, expecting this indicator to be achieved is 
realistic. 
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Again the core task team raised concerns related to the care of the infant‟s mother and agreed to 
add the following two questions: 
- “Is the mother‟s baseline / current WHO clinical stage recorded?” 
- “Has a CD4 count been done and are the results available?” 
 
The information can be accessed in the general folder for the standard HIV/ART Patient 
Summary folder or in the general clinical notes in the event that the official stationery had not 
been used. The apt domain was decided to be quality, again due to adherence to policy being 
indicative of quality of care being rendered. 
 
Social Assistance and PAP smear 
It is standard practice to conduct a social assistance evaluation and a PAP smear on all HIV 
positive women as a component of HIV Care and ART service delivery. Since this is both 
national and provincial policy it is expected as standard practice, but the core task team 
deliberated in terms of whether it was applicable to include this in this particular tool.  
 
The tracer indicator „proportion mothers with evidence of general HIV care‟ was decided upon. 
This indicator would also suggest that all other programme elements aligned to HIV care would 
be in place and not just social assistance and PAP smears. This information is accessible within 
the standard HIV/ART stationery or the continuation notes. 
 
It was decided that the following two questions would be added to the PMTCT Baby tool:  
- “Was social assistance evaluation completed?” 
This section assesses social support needs. It assesses support available to the mother at 
home, source of income and alcohol and drug use, all of which may influence adherence 
to treatment and require intervention. It also assessed whether there are vulnerable 
children, whether the infant is placed at risk and if the family is eligible for any grants. 
- “Has client had a PAP smear done and results recorded?” 
Cervical cancer presents in younger women and progresses much more rapidly with HIV 
infection. The protocol for routine PAP smears in HIV positive women has not yet been 
finalised, however we work on current best practice that HIV positive women should 
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have at least one PAP at baseline, irrespective of their age and whether a PAP has already 
been done in the last 10 years. 
 
This indicator resides within the quality domain since it speaks into adherence to the relevant 
policy.  
 
Commenced on HAART  
The HIV care and ART policy stipulates the medical criteria for commencing ART and these 
criteria should be adhered to in all clinical settings. The HIV/ART stationery is used from time 
of confirmation of the HIV status and allows for tracking of the client so that it is clear when the 
client meets the medical criteria for commencement onto life-long ART. 
 
The tracer indicator selected, was “Proportion of mothers commenced who require ART”. This 
indicator is very easy to track since the information is easily accessible in the HIV/ART 
stationery and the continuation notes (should the stationery not be used).  This indicator responds 
to policy and thus the quality domain is most suited. 
 
The core task team agreed that the following two questions should be asked since it elicits 
whether or not the mother of the HIV positive infant has been assessed for ART eligibility and 
whether she had been referred accordingly if the criteria were met. 
- “Does the mother currently meet the medical criteria for ART? “ 
The rationale is that the review of the CD4 count result and WHO clinical stage to 
determine whether the mother has met the medical criteria for ART in post-natal women 
is crucial. 
- “Has the mother commenced on ART post-delivery?” 
This question assesses appropriate access to ART for those who meet the medical criteria 
for ART and who have not commenced on ART previously. Clients who meet the criteria 
should be timeously commenced on ART provided at the facility or formally referred to 
an ART site for treatment. It is the responsibility of the facility to monitor the clients 
access to ART for all PMTCT mothers. 
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Contraceptives 
The core task team agreed that access to contraception is linked to the PMTCT programme and 
general HIV Care. Dual protection against pregnancy and sexually transmitted diseases is 
recommended for sexually active women. Since the core task team agree that the move towards 
HIV and Family planning integration is not Provincial policy, it has however been included in 
Standard Operating Procedures based on research that has been in progress within the Metro 
District. 
 
The tracer indicator “% HIV positive mothers assessed for contraception” was measured against 
the selection criteria and found to be a proxy indicator for access to comprehensive health care, 
but it would in essence not be able to measure any other PMTCT related programme elements.  
 
The core task team members decided that the question “were contraceptives needs assessed at the 
last visit and due date for repeats recorded?” would be appropriate to assess contraceptives 
another than condoms. Many women will say they are on contraceptives, even though they have 
missed their last appointment for repeat contraception, therefore due dates for the next visit for 
contraceptives should always be noted.  
 
The information required to respond to this question is found in the HIV/ART Visit Summary 
Form and if this form was not used then it should be found within the general clinical notes. The 
indicator resides within the integration domain since it facilitates integration into the general or 
comprehensive service platform.  
 
It was agreed that it would be a realistic to include this question and that the results would 
stimulate management to move more towards achieving a better place on integration. However 
with regards to standard practice of care for maternal health, all women who are sexually active 
should be offered contraceptives and condoms as a routine.  
 
Sequence of questions  
In draft 1 and 2 of the tool development, the focus was predominantly on questions and tracer 
indicators. However in session 3 the core task team deliberated on the sequence of the questions 
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and its alignment to the rest of the folder reviews contained within the Integrated HAST audit 
tool so as to effect uniformity. This would facilitate the data collection in terms of the data 
collection template and how the sheets have been constructed in order to ultimately tally through 
to provide a summary of the evaluation of audit that had been conducted.  
 
Draft 2 of the tool 
Following sessions two and three, draft 1 of the data collection tool was amended rather 
significantly to include the questions that would speak into the preliminary set of tracer 
indicators. The tool was divided into 3 sections: 
- Sampling section: in this section the numbers of folders that were sampled for both infant 
and mother was recorded, as well as those sampled but not found.  
- Infant section: eleven questions were included to address the tracer indicators relevant to 
the infant and the PMTCT Baby register 
- Mother section: thirteen questions were included to address the tracer indicators relevant 
to the mother, infant and PMTCT baby tool 
Draft 2 of the tool (Appendix C) was agreed to by the core task team members. 
 
3.7.3 PILOT OF TOOL  
The core task team decided that a small pilot would help to define or strengthen the tracer 
indicators and the data collection tools. The understanding was that this would make the tool 
more robust for formal piloting. It was decided that this small pilot would be conducted by the 
Clinician who was a core task team member and that Wynberg and Langa clinic would be 
utilised.  
 
Wynberg Clinic is a low burden clinic with no ART services. Only 24 HIV exposed babies were 
recorded on the PMTCT register for the entire year. It took 2hr to conduct the pilot, from the 
time of sampling out of the PMTCT register until completion of the tool. In general a very poor 
link between the mother and infant was found. The PMTCT care according to policy was rather 
unstructured (and all over the place) with poor record keeping especially with regards to the 
mother. There was also no dedicated PMTCT clinic and mothers brought their infants at any time 
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and at any session and any available nurse would see the infant. This clinic did not offer an ART 
service and mothers accessed this elsewhere.  
 
Langa Clinic is a high volume site with 137 HIV exposed infants on the PMTCT register at the 
time when the small pilot was conducted, averaging between 270 and 320 HIV exposed infants 
on the PMTCT programme per annum. It took 1hr 50mins to conduct the pilot, from the time of 
sampling from the PMTCT register until completion of the tool, since the register was extremely 
well completed, due to excellent oversight from the facility manager, who also provides input in 
terms of standard of care. This pilot therefore presents the best scenario in terms of care given. 
 
Feedback of the pilot was provided at session four.   
 
3.7.4 SESSION 4: Feedback from pilot to evaluate the tracer indicators 
The results of this pilot were shared electronically with the core task team members before 
session four and then formally tabled at the session. The HAST Clinician / Programme Support 
Medical Officer who conducted the small pilot, decided that it would be best to present the 
feedback by facility since the facilities were very different in terms of HAST services offered 
and the burden of disease. 
 
Lessons from the pilot at Langa Clinic  
All the infants registered had corresponding mother‟s folders completed in the PMTCT baby 
register. This may have been due to Langa having their own ART site and the mothers were on 
treatment at the same facility. In essence a very good link existed between the care for the 
mother and the infant. 
 
Sampling 
The HAST Clinician / Programme Support Medical Officer reported that the sampling was found 
to be remarkably difficult since the mother‟s often have different surnames to their infants and in 
addition to this the sampling instructions were found to be ambiguous, as follows: 
- As recommended the sampling 3months ago and she worked backwards for 6 months. 
The numbers of registered infants were counted and it was then noted that the sampling 
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options had suggested the sampling against the number of infants per year. It was 
suggested that the core task team discuss and amend this to number of infants registering 
on the PMTCT programme per month, for the next draft. 
- It was not quite clear what was meant with consecutive folders. Every second baby was 
then sampled, but this would require clarification.  
Based on this method of sampling the HAST Clinician / Programme Support Medical Officer 
managed to access all 10 infants folders including two additional folders, in the event that any of 
the folders could not be found. All of these came from the same page within the PMTCT baby 
register. 
 
Key Results 
Feeding practices were not discussed at the last visit for 90% of the babies. In 80% of infants the 
counselling form was used and consent taken. 100% of information in the PMTCT register was 
accurately recorded and complete. 
Of the mothers‟ folders sampled, 3 mothers were found to be on ART prior to pregnancy, 4 of 
them started ART at Langa during pregnancy, 2 moms were in HIV wellness care at Langa prior 
to the delivery and 1 mother was admitted to HIV care at Langa, because she presented at the 
PMTCT programme with a baby. 
 
Collection of the data on the infant 
In terms of feeding options, looking into tracer indicator „proportion of mothers with feeding 
practices discussed‟, two questions were included in the tool, i.e. „is there a record that feeding 
options and mixed feeding were discussed at each visit‟ and „was the full quota of infant feeding 
formula issued with each visit‟. The HAST Clinician / Programme Support Medical Officer 
suggested that the question, „is there a record that feeding options and mixed feeding were 
discussed at each visit‟ should either change or be omitted? The reason for this suggestion is that 
although the feeding choice was clearly recorded at the last visit, when the child is 3 months and 
older it is no longer appropriate to discuss feeding options at every visit. For most babies it was 
clearly recorded that feeding options were discussed at the first visit. It was suggested that the 
question rather ask if there is a record that feeding options were discussed at some point or 
whether the feeding choice has been clearly recorded. 
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As for the second question, „was the full quota of infant feeding formula issued with each visit‟, 
it was suggested that N/A be added into the response columns, since some of the mothers  prefer 
to buy their own formula (of which there were quite a few in the register). 
 
As for the indicator, „proportion of mothers counselling form used and consent taken‟, it was 
suggested that N/A be added to the tool when answering the two questions aligned to this tracer 
indicator, i.e. „has an HIV consent and testing form been used for the HIV PCR test‟ and „was 
the consent taken for the HIV PCR test‟. This is due to the fact that many infants test at another 
institution, e.g. a hospital and are referred to the health facility for further management. In these 
instances, the consent forms will not be included, but the result would be written in the folder or 
included in the referral letter from the referring institution. 
 
The tracer indicator „proportion of HIV exposed infants fully immunised‟ could be skewed in the 
event of a stock-out. Discussion followed on whether to record immunisations is up to date in the 
event of a stock or not. It was decided that the immunisation schedule would be added to the 
guidelines manual and that N/A would be included for legitimate reasons, i.e. stock outs that 
prevented the infant from being fully immunised.  
 
Collection of data on the Mother 
The tracer indicator „proportion of mothers with evidence of general HIV care‟ and its related 
question took significant discussion at the feedback session. It was decided that the question 
„was a social assistance evaluation completed‟, that this question is asked HIV care tool (recent 
positive diagnosis) and the ARV tool (recent ARV started). In the sample for the PMTCT Baby 
tool, many of the mothers had been known to the clinic for years before the baby was born and 
therefore the fact that their social assistance was filled in or not, did not seem to be relevant to 
current care. It was suggested that this question be omitted. 
 
Further discussion continued on the question „has mother had a PAP smear done and results 
recorded‟, that this question was very out of date for some patients, since some PAPs are delayed 
during pregnancy and for 3 months thereafter because of hormonal changes during pregnancy. 
So although many mothers did not have a PAP smear, it would be inappropriate to do so at that 
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time. In addition to that, if we decide to keep this question should we not be adding a N/A for 
moms who are ineligible and those who are at another institution for colposcopy? This question 
would also be omitted in the next draft. 
 
Lessons from the pilot at Wynberg Clinic  
Sampling 
Since the numbers are small, sequential folders were sampled which made it easy to complete the 
mother and infant sampling form without getting confused. Only 12 babies registered in the last 
5 mnths and out of this only 1 folder could not be found, while another was intentionally omitted 
from the sampling since the mother repeatedly defaulted from bringing the baby for a HIV PCR 
even after counselling.  
 
The mothers name and other details were recorded in the PMTCT register, but none of the folder 
numbers of the mothers were recorded. Twenty mother folders were selected for sampling dating 
13 months back and out of these only six folders were found. As a point of interest, CLINICOM 
(an electronic patient data base / system) was checked to see whether these mothers were 
elsewhere in the primary health care system, since CLINICOM should show all the deliveries 
that take place at the Maternity and Obstetrics Units (MOU). It was found that only six mothers 
attended at Wynberg, one mother at Matthew Goniwe and one mother at Crossroads clinic. The 
other 12 mother folders could not be traced at all.  
 
Results 
In only 30% of mother, the Counselling form was used and consent taken for the infants HIV 
PCR. The monthly columns in the PMTCT register were not marked off for formula feeding or 
breastfeeding. Therefore 0% of the mothers had there feeding practice discussed. Poor use of 
stationery was also found, with only one out of six mothers folders found, i.e. 17%. 
 
Collection of the data on the infant 
With the tracer indicator „Proportion mothers with feeding practice discussed‟, it was also noted 
that since the sampling commenced at 3 months ago and since the numbers of infants registered 
for PMTCT are small, infants who were six months old already had been sampled. At this age 
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formula is no longer dispensed and this was apparent with two infants in the sample at Wynberg 
clinic. The core task team needed to consider either adding N/A to the formula question or 
changing the question to focus on the last PMTCT related visit, rather than the last visit.   
It is also noted that breastfeeding and formula purchasing babies do not attend the clinic 
regularly. One question that arose was in terms of the baby being exclusively breastfed until 
2mnths and successfully changed to formula and in an abrupt manner, whether this is considered 
mixed feeding? Although these could be clarified in the manual, the core task team deliberated 
with regards to the value of the question on „was the full quota of infant feeding formula issued 
with each visit” when we already ask the question „is there a record that feeding options and 
mixed feeding were discussed at each visit‟ and whether the information that is received from 
both questions are essential. 
 
Two decisions were taken by the core task team: 
- Remove the question „was the full quota of infant feeding formula issued with each visit‟, 
since the tracer indicator can still remain through the use of the remainder question “is 
there a record that feeding options and mixed feeding were discussed at each visit”. 
- Change the sampling to commence 2 months ago and work backwards to accommodate 
the facilities with smaller numbers. 
 
Collection of data on the Mother 
The HIV status of only one of the six mothers was recorded in the folder. Only three of the six 
mothers have been seen at the clinic post-delivery. There is evidence that the mothers, of all 
twenty folders that were sampled, had attended the clinic when registering the baby on the 
PMTCT programme and 19 out of the 20 had a CD4 count which was recorded in the register. 
However, the recording in the folder suggests that no on-going care is provided to the mothers.  
The core task team agreed that in order for this tool to provide the robust information that is 
necessary to change practice, the tracer indicators, with the exception of the two questions 
removed on PAP smears and social assistance would remain.   
 
One recommendation that the core task team would want to make into practice based on the 
findings from this small pilot is that the mother and infant should be seen together at the initial 
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PMTCT visit. This would facilitate the fact that the mother gets some form of baseline care, it 
will also allay perceptions that the care is just for the infant and it will allow recording that will 
clarify the links between mother and infant. However, should the mother access HIV care 
elsewhere, then this will still allow for the recording of the relevant information that would 
contextualise the infant‟s care and allow for a folder to be ready for when the mother accesses 
care for anything other than ART or HIV care.  
 
As for the sampling it was decided that if any of the folders of mothers of any of the infants were 
not be available at the facility, no replacement mother folders would be retrieved.  In addition to 
this it was agreed that if the mother was last seen in the antenatal period or no HIV status is 
recorded anywhere in the folder, then further auditing of the folder would stop. It was agreed that 
a row would be included in the data collection tool that states whether or not the folder would 
qualify for further auditing. At this point the new denominator would be recorded for the rest of 
the audit. 
 
Draft 3 of the PMTCT Baby tool 
After the small pilot conducted at Langa and Wynberg, the core task team agreed on the 
indicator set and amended the data collection tools. Draft 3 (Appendix D) was produced, which 
was used for the second pilot.   
 
3.7.5    The Second Pilot 
Selection of pilot sites  
The core team wanted to determine whether the tool would be valid and reliable when applied by 
different users and within different settings, having made the suggested adjustments after the 
small pilot. A site with low volume PMTCT clients, in a setting without an onsite ART service, 
and a site with high volume PMTCT clients with an onsite ART service were again decided 
upon. In essence the selection would be similar to that of the small pilot, but with different users 
and a more refined tool.  The following sites were selected: 
 
 
 
 
 
 
 
 Page 51 
 
Sarepta clinic  
The clinic is situated in the Eastern sub-district. It has a fairly even distribution of clients that 
range from middle income to lower income socio-economic groups. The facility manager agreed 
that the site could be piloted 
 
Kuyasa clinic 
The clinic is situated in the Khayelitsha sub-district and it services a population that is 
predominantly, but not entirely low socio-economic group. The facility manager also agreed that 
the facility could be used for this pilot. 
 
Selection of the implementers 
In order to select the implementers group, PHC managers and comprehensive health programme 
managers who had previously been  involved in HAST audits were approached and enquired 
with regards to which facilities within their area of supervision would suit the site selection 
criteria.  
 
Once a few sites were identified that met the agreed criteria, facility managers were approached 
in order to determine whether they would agree to participate in this pilot. The first two sites that 
met the criteria, where the facility managers agreed to partake in the pilot, were then selected to 
be the pilot sites.  
 
Facility level staff with more than with more than 2 years‟ experience in the HAST arena at 
facility level and with previous involvement in HAST audits were then selected. The PMTCT 
coordinator for the sub-structure within which both sites were located was included in the 
implementers group. 
 
 
Training Session 
A half day training session was held for the implementers and the teams were established for the 
second pilot. Each team was allocated a core task team member, who remained available to 
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answer questions and support data collation. The training aimed to ensure that all users applied 
the tool in the same manner so that reliability would be ensured.   
The training covered the following: 
- An overview of the entire Integrated HAST audit tool was provided 
- Draft 3 of the PMTCT Baby tool was presented and comments taken 
- Mock folders and register sheets were utilised so that the tool could be completed 
- Difficulties and confusing areas were discussed and clarified 
- Discussion on potential usefulness and feasibility of the tool. The implementers were 
informed that this level of information would be required with the post pilot feedback. 
- Dates for the pilot were confirmed. 
 
Each team conducting a pilot comprised of a core task team member, the facility manager, a 
facility level staff member working in the HAST services, the PHC manager of the relevant sub-
district and a sub-district or sub-structure HAST or PMTCT coordinator. All these members had 
been involved in the application of the Integrated HAST audit tool in the past. 
 
The pilot at Kuyasa and Sarepta proceeded according to plan, with each facility being audited in 
less than 2 hours from the time of sampling until completion of the data collection tools. All 
designated team members participated as planned. In general sampling for the infant was very 
clear and did not require any further clarification. However the availability of the mother folder 
care at the same facility and no evidence existed that the mother was receiving any form of HIV 
care or ART elsewhere. The core task team members who were on the teams were able to clarify 
these and agreed that the guide for this data collection will need to be explicit in clarifying when 
a mother folder does and does not meet the criteria for inclusion and in what instances it should 
be recorded as „N/A‟ and „not found‟.  
 
3.7.6   Data Analysis 
The notes from the sessions held with the core task team were voice recorded and captured in 
writing. These notes were then captured in the form of reports and minutes and were used to 
update the next draft of the tool.  
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An Excel template was designed with built in formulas, to capture the data from the pilots. This 
spread-sheet had built-in graphs which provided a graphic representation of the data and painted 
an immediate picture on potential errors.    
  
3.7.7 Feedback workshop and final review of tool 
On completion of the pilot, the researcher collated the results and calculated proportions (most of 
the data is likely to be categorical). The results were presented back to the core task team and 
implementers to assess whether the tool produced information which was considered useful to 
improve the PMTCT programme to HIV exposed infants at facility level. 
 
During the training session, the application of the tool with the second pilot and at the feedback 
session, the implementers were afforded the opportunity to comment on the data collection tool 
and the user-friendliness of the tool. The feedback workshop was a special session arranged to 
review the pilot to ensure that each of the implementers expressed their opinion in terms of 
whether the tool was found to be feasible, whether it produced useful results and in essence 
whether it could be used to improve service rendering to the HIV exposed infant at facility level. 
 
At this feedback workshop both groups deemed the pilot successful and agreed that the data 
collection tool elicited the information required to feed into the tracer indicators.  
 
The users also agreed that the data collection tools were useful and that it provided clear 
indications in terms of where policy was adhered to and where the PMTCT service rendered to 
the HIV exposed infant required further support. It was decided that the PMTCT Baby Tool 
(folder review) should be incorporated into the Integrated HAST audit tool. 
 
The results of the second audit and the final PMTCT Baby tool are presented in Chapter 4. 
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CHAPTER 4:   RESULTS 
 
4.1 Results of the second pilot of the PMTCT Baby Tool 
The full set of results from the second pilot was collated by the researcher and is shown in Table 
4.1. These results demonstrate the usefulness of the information which the Baby PMTCT Tool 
collects. 
 
Table 4.1 Results of the second pilot  
Domain 
Tracer Indicator 
Sarepta 
Infant 
N=10 
Mother 
N=8  
Kuyasa 
Infant 
N=10 
Mother 
N=10 
Access % Mothers identified HIV positive in the clinical folder 75% 100% 
Availability  
and 
capacity 
% Facilities with stock outs of tracer drugs (ARTs) or 
consumables (infant formula) 
0% 0% 
% Folders found – Infant 100% 100% 
                     - Mother 80% 70% 
Quality 
% Mothers counselling form used and consent taken (at 6 
weeks) 
0% 40% 
% HIV PCR results available 60% 70% 
% Mothers with feeding practices discussed 20% 0% 
% Babies weighed at last visit 90% 100% 
% Correct entries in PMTCT Baby register 20% 0% 
% HIV exposed infants whose mothers are registered in the 
PMTCT Baby register 
30% 100% 
% HIV +ve mothers with HIV / ART stationery used 38% 33% 
% HIV +ve mothers WHO staged and CD4 count recorded 19% 33% 
% Commenced who require ART  - Needed ART 33% 0% 
                                                        - Commenced on ART 0% 0% 
Continuity % Clients with future management plan noted at last visit -                                                        
Infant 
40% 20% 
Mother 0% 67% 
Integration 
% HIV exposed infant fully immunised 80% 0% 
% HIV +ve mothers assessed for contraception 13% 100% 
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Access 
Maternal access to ongoing HIV care was measured by the proportion of mothers identified as 
HIV positive in the clinical folder. This indicator and question was included, since concerns were 
raised that mothers who are HIV positive are not accessing on-going HIV care. The only way to 
ensure that on-going care is being provided is by identifying them as HIV positive in their 
folders, so that when these mothers access other health services they can be managed holistically 
by the attending clinician, since their HIV status would be available.  
 
All (n=3) of the mother folders that met the criteria for inclusion at Kuyasa clinic were found to 
indicate that the mother was HIV positive. Out of the 8 (N-8) mothers found eligible at Sarepta, 
75% (n-6) of them specified that the mother was HIV positive. This means that, while the infant 
is accessing care by being registered on the PMTCT programme, their mothers are not known to 
be HIV positive and so are not accessing ongoing care for HIV. 
 
Availability and Capacity 
The availability of infant feeding formula and ART drugs for rendering the PMTCT programme, 
was measured by the proportion of facilities with stock outs of tracer drugs (ARTs) or 
consumables (infant formula). This indicator and question was included in the facility manager‟s 
questionnaire to identify whether stock outs had been experienced, since mixed feeding and the 
non-availability of ART drugs would negatively impact on the HIV status of the HIV exposed 
infant.  
 
None of the two facilities had any tracer drug or consumable stock outs related to the PMTCT 
programme, i.e. AZT, NVP, Truvada and Pelargon or Melegi. These items were available and 
the evidence for this was found in the bin cards. Should any of the infants at the 2 sites test HIV 
PCR positive at 6 weeks, this would not be as a result of poor access to ART drugs and infant 
feeding formula. 
 
Availability of the mother and infants medical records was measured by the proportion of folders 
found – infant and mother. In order to ensure that HIV care provided to the mother and infant is 
continuous, the folders should be accessible. Each facility should have a filing system in place 
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that would facilitate access to all folders. All (N=20) infant folders that were sampled, were 
found and reviewed between the 2 sites. Of the 10 (N=10) folders that were sampled at Sarepta 
clinic, 20% (n=2) of the folders were not found. All (N=8) of the mothers folders that were found 
at Sarepta clinic, met the criteria for sampling.  
 
At Kuyasa clinic out of the total number of (N=10) folders that were selected, 40% (n=4) failed 
to meet the criteria for sampling, since these mothers were not seen at the health facility post-
delivery. The remaining 6 folders met the criteria for sampling (N=6), but only 50% (n=3) of 
them were found. 
Since a standard filing system for health facilities is in place, it was not expected that these many 
folders would not be accessible.  
 
Quality 
The quality of counselling is measured by the proportion of mothers counselling form used and 
consent taken (at 6 weeks). A standard recording form, the “HIV Consent and Testing Record for 
Adults and Children” has been in use since 2009 for the recording of all counselling provided 
and consent taken for HIV. This form contains prompts that facilitates accurate record keeping 
and serves as the legal document for consent. At Sarepta clinic none (n=0) of the babies tested 
(N=10) for HIV PCR had evidence that the mother was counselled or that consent for the test 
was taken. At Kuyasa, only 40% (n=4) of the total sampled infants (N=10) had evidence that the 
prescribed form was used. This reflects that the use of this form is poor and requires intervention. 
The National and Western Cape policy requirement that written consent for HIV testing should 
be taken, was not adhered to.  
 
The quality of the entire PMTCT programme is measured by the outcome of the HIV PCR 
results of the infant and this is measured by the proportion of HIV PCR results available. The 
National Health Laboratory Services send all results to the facilities where the tests are 
conducted and it is standard practice that these results are filed in the client folder. At Sarepta 
clinic 60% (n=6) of HIV PCR results of the infants (N=10) were found in the folder and 70% 
(n=7) of the total infants (N=10) were found at Kuyasa clinic. None of the HIV PCR tests were 
conducted at other facilities. The absence of a test result means that no evidence of the outcome 
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of the HIV exposed infant exists after the mother and infant have been on the PMTCT 
programme. 
The quality of infant feeding practices was measured by the proportion of mothers with feeding 
practices discussed at the last visit. Mixed feeding increases the infant‟s chance of testing HIV 
PCR positive at 6 weeks. It is thus imperative that in order to ensure that the policy is adhered to, 
that infant feeding practices are discussed. Only 20% (n=2) of the total (N=10) infants at Sarepta 
clinic had evidence in the folder that infant feeding was discussed with their mother. At Kuyasa 
clinic none (n=0) of the infant folders reflected that infant feeding was discussed with their 
mothers at the last visit. This indicator was very poorly achieved at both clinics and a huge risk 
for mixed feeding thus presents itself. 
 
In order to ensure that the dosage of the ART drug NVP was prescribed according to the infant‟s 
weight, as the policy stipulates, the proportion of babies weighed at last visit was measured. 
Quality care to the infant is ensured by weighing the infant so that the correct drug dosage can be 
prescribed and also to determine whether growth faltering is taking place. Sarepta clinic achieved 
90% (n=9) of all infants (N=10) being weighed at the last visit and Kuyasa clinic achieved 100% 
(n=10) for this indicator. The quality of care in terms of drug prescription and drug issue was 
well achieved. 
 
Quality record-keeping is ensured by measuring the proportion of correct entries in the PMTCT 
Baby register. It was expected that the 6 week HIV PCR test result, Co-trimoxazole at 6 weeks, 
initial and on-going feeding choice and provision of milk formula to date (where applicable), is 
correctly entered from the infants folder into the PMTCT Baby register. At Sarepta clinic the 
register entries were only 20% (n=2) correct of the total (N=10) entries sampled and none (n=0) 
of the entries at Kuyasa clinic were completed correct from the infant folders (N=10). Poor 
translation of information from the infant folders to the PMTCT Baby register was noted and this 
translated into poor information flowing from the register into the departmental reporting system. 
 
The quality of care offered to the HIV positive mother could be detrimental or beneficial to the 
HIV exposed infant. In order to ensure that the mother is adequately managed, this is measured 
by the Proportion of HIV exposed infants whose mothers are registered in the PMTCT Baby 
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register. The aim was to be able to track that the mother was managed according to HAST 
policies. 
 
At Sarepta clinic 50% (n=5) of the mothers of HIV exposed infants were recorded in the PMTCT 
Baby register with regards to their PHC number at 30% (n=3) and CD4 at 70% (n=7) being 
recorded. Since 30% (n=3) of the maternal folder numbers were recorded in the PMTCT Baby 
register, but 80% (n=8) of the mothers folders were located, it reflects that other mechanisms for 
locating these folders had to be used, i.e. other electronic patient record system. At Kuyasa clinic 
this indicator was 100% (n=10) achieved with regards to the PHC folder and the CD4 count 
recorded. Also note that maternal folder number and CD4 recorded in the PMTCT register would 
speak to the quality of care domain directly for the mother and indirectly for the infant.  
 
Quality of care to the mother is ensured through adherence to policy and this was measured by 
the proportion of HIV positive mothers with HIV / ART stationery used. The standard HIV / ART 
stationery is a National and Provincial policy requirement and its use facilitates adherence to the 
HIV treatment policy. Of the mother folders (N=8) that were found and used at the Sarepta 
clinic, only 38% (n=3) of them had the standard HIV/ART stationery used in the mothers folder. 
In the Kuyasa clinic, only 3 of mother folders that were eligible (N=6) could be found and only 
33% (n=1) of these folders had the standardised HIV/ART stationery used. So in summary at 
Kuyasa clinic out of the total infants (N=10) sampled, only 6 mothers met the criteria for 
inclusion and of these only 3 of the folders were found. Then of the 3 that were found, only 1 
used the standard HIV/ART stationery. Again since Kuyasa clinic is an ART site, it was 
expected that the standard HIV/ART stationery would be in use in all HIV positive clients. This 
would require intervention. 
 
The quality of care to the mother was measured by the proportion of HIV positive mothers who 
were WHO staged and had there CD4 count recorded in their folders. The WHO staging should 
be updated when new stage defining illnesses are noted and a CD4 count is required 6 monthly 
pre-ART, to assess disease progression and every 12 months for those on ART. Only 13% (n=1) 
of the total (N=8) mothers at Sarepta clinic were WHO staged and 25% (n=2) of the total (N=8) 
mothers had a CD4 count recorded. This indicator was then calculated at 19% achieved. At 
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Kuyasa clinic the WHO staging and CD4 count of 33% (n=1) of the eligible mothers (N=3) was 
achieved. This reflects poor adherence to policy with regards to HIV care at both sites. 
 
The quality of care provided to the mother is further measured by the proportion of HIV positive 
mothers commenced on ART, who require ART, i.e. needed ART and commenced on ART. 
Medical eligibility criteria for commencement on lifelong ART are set out in the HIV Treatment 
policy guideline and in order to ensure that quality care is provided to the mother, evidence of 
this should be accessible in the mother‟s folder. Thirty three percent (n=1) of the total number of 
mothers (N=3) was recorded as eligible for ART at Sarepta clinic. However, this mother was 
never commenced on ART nor is there record that she was referred for ART. At Kuyasa clinic, 
only 1 mother of those folders that were eligible for sampling (N=6) was not on ART and this 
mother was not yet eligible for lifelong ART. 
 
Continuity 
The continuity of care for the mother and infant was measured by the proportion of clients with 
future management plan noted at last visit – infant and mother. It is expected standard practice 
that the mother and infant are followed up until such time that they are either referred for care 
elsewhere, commenced on ART or that the infant is discharged with a HIV PCR negative result. 
Of all (N=10) the infants at Sarepta clinic, 40% (n=4) of them had a management plan noted at 
the last visit. At Kuyasa clinic 20% (n=2) of infants (N=10) had a management plan noted. As 
for the mothers, none (n=0) of them (N=8) had a management plan noted at Sarepta clinic and 
67% (n=2) of the total eligible mothers (N=3) was achieved at Kuyasa clinic. Both facilities have 
achieved poorly in this indicator and continuity of care to both mother and infant was 
compromised. 
 
Integration 
In order to integrate service delivery for the infant in comprehensive package of care, the 
measure of the proportion of HIV exposed infant fully immunised, was used. Immunisations are 
seen as a proxy indicator for access to comprehensive health care since all infants should be fully 
immunised unless a medical reasons exists that indicates otherwise. Immunisation of all infants 
should be up to date according to the infant‟s age. Of the total infants (N=10) sampled at Sarepta 
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clinic, 80% (n=8) were fully immunised. At Kuyasa clinic none (n=0) of the total infants (N=10) 
sampled were fully immunised. This could arguably be due to the fact that the volume of infants 
seen at the Sarepta clinic is lower and the staff are thus able to address standard care better. 
However, this could also be a recording-keeping gap at Kuyasa clinic, since it seems highly 
unlikely that all of the infants were missed opportunities with regards to immunisations.   
 
The integration of the care for the mother into the comprehensive service was measured by the 
proportion of HIV positive mothers assessed for contraception. This would reflect access to dual 
protection against pregnancy and STIs, as well as being a proxy indicator for access to 
comprehensive health care. At Sarepta clinic only 13% (n=1) of the total number of mothers 
sampled (N=8) were assessed for contraception and at Kuyasa clinic all (n=3) the mothers were 
assessed for contraception. Integration of the care for the mother at Sarepta clinic, into 
comprehensive care and in terms of access to dual protection requires some attention. 
 
4.2  Final version of the tool  
Following feedback of the results to the core task team and implementers and final discussions, it 
was agreed that the questions in the draft 3 of the Baby PMTCT Tool, which was piloted, would 
remain unchanged. The final tool (Appendix D) which only differs from draft 3 in terms of 
formatting, responds to the five evaluation domains and a set of 15 indicators, as shown in Table 
4.2. It was felt that this tool would give programme and facility managers‟ sufficient information 
to improve the quality and coverage of the PMTCT service rendered to the HIV exposed infant. 
The facility manager‟s questionnaire was also amended in order to feed into these indicators. 
 
Table 4.2.  Domains and Indicators for the PMTCT Baby Tool 
Domain Tracer Indicator Rationale Questions 
A
cc
es
s 
Proportion of  
Mothers  identified 
HIV positive in 
clinical folder 
Postnatal women on the 
PMTCT programme may 
attend clinic for different 
reasons and to ensure access 
to HIV care, an HIV status 
must be indicated.  
Is the mother identified as 
HIV positive in the clinical 
folder? 
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A
v
a
il
a
b
il
it
y
 a
n
d
 C
a
p
a
ci
ty
 
Proportion of 
facilities with stock 
outs of tracer drugs 
(ARTs) or 
consumables (infant 
formula) 
To ensure access to essential 
ART drugs and infant feeding 
formula to provide quality 
care according to the PMTCT 
policy 
Facility Manager‟s 
Questionnaire covers all 
tracer drugs and 
consumables, including 
Pelargon Formula Feeding 
for the PMTCT baby 
Proportion of folders 
found 
For both infant and mother, it 
is important that clinical 
information is available so 
that quality of care and 
continuity of care can be 
ensured 
Number of infant folders 
retrieved. 
Number of infant folders 
requested for review but not 
found. 
Number of mother folders 
found that meet criteria. 
Number of mother folders 
found that fail criteria  
Number of mother folders 
not found 
Q
u
a
li
ty
 
Proportion of  
mothers counselling 
from used and 
consent taken 
 
Use of the standard “HIV 
Consent and Testing record 
for Adults and Children” 
improves the quality of 
services as it provides a 
prompt and guide to users 
 
Has an HIV consent and 
testing form been used for 
the HIV PCR test? 
It is WCP policy requirement 
that written consent is taken 
for an HIV test. The 
requirement for infants is 
consent from the parent or 
legal guardian. 
 
Was consent taken for the 
HIV PCR test? 
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Q
u
a
li
ty
 
Proportion of HIV 
PCR results 
available 
If a PCR was done, the 
expectation is that  that result 
would be in the infants folder 
so that the appropriate future 
action can be taken 
Is the HIV PCR test result 
available in the folder? 
 
 
 
 
Proportion of 
mothers with 
feeding practice 
discussed 
It is expected that feeding is 
discussed at every visit since 
HIV transmission can occur 
through mixed feeding. 
Is there a record that feeding 
practice was discussed at the 
last visit? 
Proportion of Infants 
weighed at last visit 
Weight will determine the 
correct dose for medication 
and early detection for growth 
faltering. Infant should be 
weight at every visit. 
Was the infant weighed and 
weight recorded at the last 
visit? 
Proportion of correct 
entries in PMTCT 
register 
Helps to assess the accuracy 
of the PMTCT register. Data 
from register is used to 
monitor programme 
performance and it is 
important that all elements 
correctly reflects information 
from the folders. It also 
ensures that appropriate care 
is provided.  
Is the 6 week PCR test result, 
cotrimoxazole at 6 weeks, 
initial and ongoing feeding 
choice and provision of milk 
formula to date (where 
applicable) correctly entered 
from the clients folder into 
the PMTCT baby register? 
Proportion of HIV 
exposed infants 
whose mothers are 
registered in the  
PMTCT register 
If the mothers PHC folder 
number if reflected it allows 
maternal and infant care to be 
inked more readily.  
 
 
Does the mother of this 
infant have her PHC folder 
number recorded in the 
PMTCT register? 
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Q
u
a
li
ty
 
CD4 counts are monitored 6 
monthly for those not on ART 
and annually for those on 
ART. This result is needed to 
determine if the mother is 
receiving the appropriate 
package of care.  
Does the mother of this 
infant have a CD4 result 
recorded in the PMTCT 
register? 
Proportion of HIV 
+ve mothers with 
HIV/ART stationery 
used 
Use of standard HIV/ART 
stationery improves the 
quality of services as it 
provides a prompt and guide 
to clinicians 
Has the standard HIV/ARV 
stationery been used? 
Proportion of HIV 
+ve mothers WHO 
staged and CD4 
count recorded 
Both WHO staging and CD4 
are required in order to 
provide an appropriate 
package of care 
Is the mother‟s baseline / 
current WHO clinical stage 
recorded? 
Has a CD4 count been done 
as per CD4 protocol and are 
results available? 
Proportion of 
mothers commenced 
who require ART 
Assesses the appropriate 
access to ART for those who 
meet the medical criteria and 
who have not commenced 
previously 
Does the mother currently 
meet the medical criteria for 
ART? 
Has mother been commenced 
on ART post-delivery? 
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C
o
n
ti
n
u
it
y
 
Proportion of clients 
with future 
management plan 
noted at last visit 
If any problem is noted for 
either the mother or infant, 
there must be a management 
plan recorded to investigate, 
monitor or treat the problem. 
Was an appropriate 
management plan noted at 
the last visit? (Infant) 
Was an appropriate 
management plan noted at 
the last visit? (Mother) 
In
te
g
ra
ti
o
n
 
Proportion of HIV 
exposed infants fully 
immunised 
It also reflects whether the 
infant has received 
comprehensive package of 
care.  
Fully immunised infants have 
a significantly reduced risk of 
contracting communicable 
diseases.  
 
Did the baby receive the 
Birth, 6 and 10 week 
immunisations as per 
schedule? 
Proportion of HIV 
+ve mothers 
assessed for 
contraception 
To ensure that the HIV +ve 
client is accessing a 
comprehensive package of 
care and offer dual protection 
against pregnancy and 
sexually transmitted 
infections.  
Were the contraceptive needs 
assessed at the last clinical 
visit and due dates for repeats 
recorded? 
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CHAPTER 5:  DISCUSSION  
 
Introduction 
The researcher set out to develop a tool, pilot it and in-so-doing engaged local programme 
managers in a participatory process to develop a tool that would be locally applicable and 
relevant, and captures the local management expertise. Through this process the evaluation 
domains have been identified that were required to measure quality of care of HIV exposed 
infants in the PMTCT services at primary care level. An indicator set for the evaluation domains 
has been developed. The tool was piloted twice and through feedback from the core task team 
and implementer groups, it could be established whether or not the tool was deemed feasible and 
whether the information that it generated was considered useful.  
 
5.1   The process of developing the PMTCT Baby tool 
The use of Benson and Clarks steps in developing the PMTCT Baby tool 
The approach for developing the PMTCT Baby tool was in accordance with the four steps in the 
Guide for Instrument Development and Validation as proposed by Benson & Clark (1982). All 
thirteen steps within the four phases were directly applicable and provided a helpful structure for 
the development of this tool. The use of the Benson & Clarks phases and steps also facilitated 
content development, as noted by Hasdai, Jessel & Weiss (1997), in their study on the 
development of an instrument to measure the use of a computer simulator in training children 
with disabilities.  
 
Having used the four phases in this study, it was noted that the steps of the second pilot and the 
feedback of the results of the pilot fell between the third and fourth phases of Construction and 
Quantitative Evaluation in Benson & Clarks flowchart (1982). This was due to the fact that the 
second pilot was seen as both a form of quantitative evaluation and validation of the tool. 
Although other users of this framework have collapsed these two phases when applying the 
approach due to this blurred line (Desrosiers, Hebert, Dutil & Bravo, 1993 and Boyce, Gowland, 
Hardy, Rosenbaum, Lane, Plews, Goldsmith & Russell, 1991), the researcher decided that in 
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order maintain the structure that this approach provided, the PMTCT Baby tool would be 
developed using all four phases of tool development.  
 
Capturing the local programme managers expertise  
In engaging the core task team in a participatory research process, the researcher allowed them to 
own the tool through all the stages of its development, thus breaking the conventional mould of 
research. The core task team was responsible for deciding that the tool needed to dovetail the 
Integrate HAST audit tool and that the same set of domains would be used, determining what the 
tracer indicators would be, developing the data collection tool and piloting the tool through two 
rounds. The core task team will continue to be part of the process of further validation and 
amendment.  
 
The strengths displayed by the core task team, was evident in the fact that they were involved in 
the development and use of previous folder review data collection tools that formed part of the 
Integrated HAST audits. They thus understood the basic principles around developing and using 
these data collection tools. These experts were familiar with challenges previously experienced 
and were thus able to flag these challenges early in the process of developing the PMTCT Baby 
tool. 
 
Weaknesses that came to the fore were that the members were previously accustomed to 
focusing on the questions that should be included in the data collection tools and then worked 
their way back to the tracer indicators. This would often result in a question having to be drafted 
and re-drafted until it could feed into an indicator. This delayed the agreement on the indicator 
set. As the sessions progressed this process became easier as the point of departure for the 
discussion became clearer.  
 
Participatory research remained the process that was followed when engaging the implementers 
in piloting and modifying the tool. The strength of including the users in the process of tool 
development, allowed for them to clearly state what did and did not make sense when 
interpreting the questions on the data collection tool.  
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In order to allow the entire spectrum of HAST programme to be audited at the same time, using 
the same resources (human and financial), it was agreed that the PMTCT Baby Tool will be 
incorporated into the Integrated HAST audit tool. This process will be supported by the core task 
team which will continue to meet beyond this research process as a Provincial HAST audit task 
team and which will also facilitate the integration of quality improvement methods (action plans) 
to be implemented and monitored simultaneously.  
 
5.2  Challenges in Interpreting Policy  
According to both HAST expert groups – the core task team and the implementers -  the biggest 
lesson learnt from the developing indicators was that policy interpretation and implementation is 
not as clear and straight-forward as had been assumed. For example, the PMTCT policy states 
that the dose of Nevirapine prescribed must be calculated according to the weight of the infant; 
however it does not specify how frequently an infant should be weighed. As they debated the 
frequency that an infant should be weighed, the core task team recognised the need for policy to 
be accompanied with an implementation guide. The policy also stipulates that the mother should 
be counselled in preparation for the infants HIV PCR and that she should provide consent, but it 
does not clearly define that the use of the standard „HIV Consent and Testing Record for Adults 
and Children‟ form is compulsory. As provincial and Cape Town (MDHS and CoCT) 
programme managers, the core task team used the opportunity afforded by the tool development 
to set guidelines and standards for the Western Cape Province.   
 
There is a body of literature in the field of policy analysis which explores how and why 
implementers often interpret and implement policy differently from what the policy designers 
intended (for example, Gilson and Raphaely, 2008; Gill, Shiffman, Schneider, Murray, Brugha & 
Gilson, 2008). This literature suggests that the implementation of policy is highly influenced by 
the front line staff. For example, in Tanzania the implementation of the exemptions policy for the 
community health fund, varied significantly between the various wards since the policy was not 
deemed to be explicit enough (Kamuzora & Gilson, 2007).If policy is not clear and mindful of 
service delivery level realities, this could influence the degree to which policy is changed at the 
implementation level (Gill et al, 2008; Hill & Huppe, 2002). In a meta-analysis conducted on the 
implementation of clinical policy guidelines (Francke, Smit, deVeer & Mistiaen, 2008) it was 
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revealed that policy implementation varied from one clinical setting to another, when the policy 
neglected to clearly define which clinician/s it was intended for. 
 
5.3   Local applicability, relevance and usefulness of the PMTCT Baby tool 
According to Nuefeld, Stet, Riviera, Valle, Grados, Uriega & Lopez (2011), although evaluation 
is an integral part of the design and implementation of health programmes, the use of evaluation 
results for improving programme implementation and decision-making is limited in developing 
countries. Habicht, Victora & Vaughan (1998), further state that the main objective of an 
evaluation is to influence decision-making and the evaluation design should thus be based on the 
level of decision-making that is required.  
 
At facility level, the facility managers take the ultimate responsibility for all activities performed, 
services rendered and programmes offered. They have to make decisions with regards to all 
implementation aspects in all programmes. These programmes include all HAST, chronic 
diseases of lifestyle, maternal child and women‟s health policies, the expanded programme on 
immunisations, amongst others. The facility managers have agreed that they could gain better 
control over the PMTCT programme with this tool, since it helps them to identify various gaps 
and to respond to them appropriately, through making informed management decisions. For 
example the following facility level actions are suggested by the pilot results and would improve 
the quality of the PMTCT programme: 
- There are quick wins to be made in terms of record-keeping and transfer of data from the 
client‟s folders into the PMTCT Baby register. This would improve the achievement of 
two of the indicators in the quality domain. With the auditing of pre-determined 
objectives, which is an annual Information Management quality assurance audit, the 
evidence in the registers would not be in-keeping with that of the records in the folder. It 
is thus imperative that the register should accurately reflect the applicable information 
contained in the folder.   
- Ensuring that the filing of HIV PCR results at the registry of the facility is conducted as 
soon as possible after receipt, will improve the access to HIV PCR results for the 
attending clinician and also provide evidence of the outcome of the entire PMTCT 
programme. 
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- Formalising the use of the standard HIV Consent and Testing record for adults and 
children and the HIV / ART stationery when conducting an HIV PCR test and when the 
mother tests HIV positive, respectively, will improve record-keeping and with the 
prompts contained in these stationery, the quality of care to both mother and infant would 
be improved. 
- Evaluating the filing system at the facility and ensuring that this is aligned to the 
prescribed departmental filing system, will ensure that folders are located. Available 
folders will facilitate continuity of care for mothers and infants.  
- Conduct an assessment of staff training and levels of experience in order to make 
decisions with regards to appropriate placement of staff within the health facility and to 
identify the need for training, in order to render quality care. The gaps identified in the 
results of this tool, could be significantly reduced if the most appropriately trained 
clinical staff are placed in the best suited clinical setting. 
 
The information generated by the tool not just found to be of use at facility level, but also 
revealed various areas that could be improved at sub-district and provincial level. The tool 
identified actions which could be implemented at sub district and provincial level to strengthen 
the PMTCT programme. For example, at sub district level the pilot identified that there is a need 
to expand training on the PMTCT policy, a responsibility of the HAST coordinators, and at a 
provincial level, to add implementation guidelines on the importance of weighing infants to 
determine the Nevirapine dosage and on ensuring good feeding practices and the absence of 
mixed feeding. The pilot also identified that the general child health stationery does not make 
provision for regular recording of infant feeding practices; this will require attention at provincial 
level.  
 
The PMTCT coordinators provide PMTCT programme support to the sub-structure and were 
part of the „implementers‟ and thus included in the training and piloting of the tool. They agreed 
that the tool was an excellent aid in assisting them with their core function of system 
strengthening of the PMTCT programme and the delivery of support at the coal-face. They have 
to trace the infant with an HIV PCR positive result retrospectively, in order to identify if and 
where the delivery of the PMTCT programme failed the mother and infant. Since data collection 
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tools already exists for the PMTCT services rendered antenatally and during the intrapartum 
period, the PMTCT baby tool would now provide guidance in terms of the process of tracing the 
PMTCT service rendered to the HIV exposed infant. The role of the PMTCT coordinators also 
includes ensuring that the PMTCT Baby register is correct and complete and that the appropriate 
stationery is utilised. The PMTCT baby tool elicits this information which the PMTCT 
coordinators can respond to. 
 
Feasibility of the use of this tool and information 
Programme and facility managers have agreed that it is feasible to conduct the evaluation of the 
PMTCT programme on an annual basis when conducting the Integrated HAST audit tool in order 
to compare performance improvement from one year to the next. The application of the PMTCT 
Baby tool will thus not require any additional human resources. They also stated that through by 
applying this tool they felt that they became more familiar with the content of the programme, 
since they are responsible for various programmes that require their focus.  
 
Use of the tool for quality improvement 
The perceived quality of the health service rendered to the public cannot be easily defined, but a 
general sense from health service users (Schneider & Palmer, 2002), is that their symptoms are 
not always addressed and they also perceive a sense of prejudice to different class and race 
groups. This raises the fact that a constant attempt towards quality improvement should be made. 
Quality improvement is defined by Batalden & Davidoff (2007) as a combined effort of all role-
players (healthcare professionals, researchers, clients and their family members) that strives 
towards improved system performance, better professional development and better patient 
outcomes. The PMTCT baby tool has shown that it can produce information that will identify the 
need for professional training, reveals areas where the system can be improved and ultimately 
improve patient outcomes through facilitating adherence to policy. 
 
In the five evaluation domains, fifteen new tracer indicators have been added to evaluate the 
service rendered to the HIV exposed infant and nine of these tracer indicators belong to the 
quality domain. The core task team agreed that in order to improve quality, significant emphasis 
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had to be placed on the quality indicators and in-so-doing enhance the clients experience within 
the public sector. 
 
Øvretveit (2004) describes the four approaches to quality improvement. One approach is to take 
corrective action in instances where practice has fallen short of the expected standard, through 
using the problem solving method. This is the approach used in the application of the Integrated 
HAST audit that the PMTCT Baby tool will be part of.  Since facility managers play a critical 
role in assuring quality at facility level, it is essential that they are familiar with the PMTCT 
programme. According to Øvretveit (2004), an important way to improve quality is through 
developing the facility manager‟s skills, which would ultimately skill them in more appropriate 
resource utilisation. Facility managers were included in the development of this PMTCT Baby 
tool to ensure that it would be useful and understandable for this management cadre.  The facility 
managers involved in the pilot described the training experience as „eye-opening‟ experience 
voiced how this in itself allowed for them to engage practice and personnel and finance 
allocation differently. 
 
CERPOD (2003) reveals a series of scenarios that show how the use of available data in 
registers, folders and monthly tally sheets, can be used to evaluate the service being rendered and 
establish the capacity for improvement in order to improve quality. Similarly in a participatory 
quality improvement intervention, Doherty, Chopra, Nsibande & Mngoma (2009) show how, 
through the development and use of data collection tools to assess the PMTCT service rendered 
in KwaZulu-Natal, information was used to improve the quality of the service through the 
development of action plans to address areas of weakness. Evidence exists to substantiate that an 
evaluation of a service in a well thought through manner, does produce results that can be used to 
improve the quality of the service being rendered (Doherty et al, 2009) 
 
Audit and feedback can be effective in improving professional practice (Rowe, de Savigny, 
Lanata, & Victora, 2005; Jamtvedt, Young, Kristoffersen, O'Brien, Oxman, 2006) and in 
resource poor settings, where the adherence to policy baseline was low, a review suggested that 
an audit and its feedback had positively influenced adherence to policy (Pattinson, 2006).  
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5.4   Validity of measure  
It is acknowledged that a valid tool for a first world setting will not necessarily be valid in a 
developing world, so measurement validity reflects the extent to which a tool measures what it 
intends on measuring in a particular context (Portney & Watkins, 2000). In this instance local 
experts and local users have been involved in defining the purpose of the tool and developing it 
to make it relevant to the local context. A valid test must be reliable, which means that the 
measurement is relatively free from error according to Portney & Watkins (2000). There are 
various approaches to validity testing and “all types of validity testing address the degree of 
confidence that we have in the inferences we draw from” this tool (Portney & Watkins, 2000: 
81). For the purpose of the development of this tool the team of experts looked at face and 
content validity. It was not possible to look at criterion validity because no gold standard tool 
currently exists. 
 
Face Validity 
According to Portney & Watkins (2000: 82), “face validity indicates that an instrument appears 
to test what it is supposed to and that it is a plausible method for doing so”. Face validity was 
ensured through the involvement of the core task team and the implementers groups. Since face 
validity is deemed weakest of all measures of validity, it was imperative that this was 
strengthened by the involvement of the relevant experts and stakeholders who were 
knowledgeable in the field of HAST and instrumental in determining whether or not this tool 
would be useful.  
 
Feedback at the workshop after the second pilot with regards to the tools usefulness came 
predominantly from the facility managers and the PMTCT coordinators. They accepted the 
indicators as valid measures of the PMTCT programme to HIV exposed infants.  
 
Content Validity 
According to Portney & Watkins (2000: 83) content validity is the “adequacy with which the 
universe is sampled by a test” and in this instance the test refers to the PMTCT Baby tool that 
has been developed. Content validity in this study was ensured by reviewing the literature and 
through having engaged the core task team in defining the domains to be measured so that the 
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“content universe” of PMTCT care to HIV exposed infants could fully be assessed. Although 
this was essentially a subjective process, it evolved out of a process of planning, construction and 
quantitative evaluation to ultimately ensure validation of the tool.  
 
Portney & Watkins (2000) state that the theoretical basis for a tool are reflected through its 
component parts and this can only be achieved following a thorough, rational evaluation of the 
tool‟s objectives. Since the purpose of the tool was to evaluate the PMTCT service offered to the 
HIV exposed infant, the tool had to reflect the level to which the PMTCT policy and protocol 
have been adhered to.  
 
When developing the PMTCT Baby tool, no comparisons could be made with other instruments 
which meant that it was not possible to measure criterion validity (Portney & Watkins, 2000). 
 
5.5   Reliability 
Joppe (as cited by Golafshani, 2003: 598) defines reliability as “the extent to which results are 
consistent over time and an accurate representation of the total population under study is 
referred to as reliability and if the results of the study can reproduce under similar methodology, 
then the research instrument is considered to be reliable”.  
 
To strengthen reliability, the implementers who were involved in the pilot were trained on the 
rationale and use of the tool. They were provided with a guide which explained how to use the 
data collection tool and a core task team member was provided to support them. The 
presentations used in the training session will serve as a model for the future development of a 
training package to accompany the tool.  
 
The pilot helped to identify a tracer indicator that that did not measure what it had intended to 
measure: “proportion of HIV exposed infants whose mothers are registered in the PMTCT Baby 
register”. In order to be considered registered the mother had to have both their own folder 
number and their CD4 count recorded in the register. The pilot showed that the quality of record-
keeping in the register was too poor to assess this reliability.  
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5.6   Limitations: 
In hindsight both groups of HAST experts felt that the second pilot should have included a larger 
sample size but it was also clear that in order to remain within the sampling period (not 
exceeding six months) that this would not always be possible at some of the facilities. 
  
The PMTCT Baby tool is a quantitative tool and not a qualitative tool. Also, it makes use of 
tracer indicators rather than a full set of indicators to assess programme performance. When a 
tracer indicator indicates an area of poor performance it is necessary to do a fuller investigation 
which might need to include qualitative approaches.  
 
The tool does not track the care rendered to the infant between delivery and the time that the 
mother accesses care at the health facility. Experience within the PMTCT programme in Cape 
Town suggests that this time period could be anywhere between 1 and 4 weeks. The tool also 
will not be able to track the quality and gaps in care that is rendered to the infant and mother 
beyond 6 months when breastfeeding and formula feeding would stop. PMTCT policy advocates 
for tracking the HIV exposed infant, who tested HIV PCR negative at 6 weeks, until 18 months 
of age. The PMTCT baby tool does not make provision for this. The core task team agreed that 
since the routine data has not sufficiently responded to this policy position as yet, the tool would 
be amended at a later stage. 
 
Most of the core task team members have been involved in the development of the Integrated 
HAST audit tool and this presents a degree of researcher bias in making decisions on appropriate 
evaluation domains and the purpose of the tool. Yet it is also not unreasonable to argue that the 
most appropriate local PMTCT tool would be one that dovetails with the existing Integrated 
HAST audit tool.   
 
5.7   Generalisability: 
Vaismoradi (2009) defines generalizability as the extent to which findings from a study apply to 
a wider population. This tool evaluates the PMTCT programme as it is offered to the HIV 
exposed infant at primary care facility setting in Cape Town. It will be applicable to the HIV 
exposed infant in a Primary Care setting elsewhere in the Western Cape Province, since the 
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policy remains the same. It will however not be applicable for use at secondary and tertiary 
institution due to protocol variances at these levels of care, especially since specialist care is 
provided at that level and since pre-term infants are cared for at these levels with different drug 
regimens. The tool however is adaptable and could be adapted for these settings, should the need 
be expressed. 
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CHAPTER 6 CONCLUSION AND 
RECOMMENDATIONS 
 
6.1  Conclusion 
A tool to evaluate the PMTCT service rendered to the HIV exposed infant was developed in a 
participatory manner along with experts in the HAST programme arena and key users of the tool. 
Benson & Clarks (1982) approach to tool development proved to be exceptionally useful in 
providing structure to the process. Face and content validity was ensured, but criterion validity 
could not be measured. Reliability was ensured in the pilot through training all users on how to 
apply the tool, by providing them with a guide for the data collection tool and by allocating a 
core task team member to support each pilot team.  
 
The usefulness of the tool at facility, sub-district and provincial level was evident with regards to 
facilitating decision-making and quality improvement and establishing programme effectiveness. 
The tool allowed for the identification of weakness in current programme support and delivery 
and suggested actions that could be taken at a facility, sub-district and provincial level. This tool 
can be used in the same or similar settings throughout the Western Cape Province and with 
minor adaptations, it will be applicable to secondary and tertiary settings as well. The tool makes 
explicit, a set of standards that are implicit in the current PMTCT policy. Programme managers 
involved in the development of the tool have realised the need for policy implementation 
guidelines to accompany the policy.  
 
6.2  Recommendations 
6.2.1 The use of the tool 
The PMTCT baby tool dovetails with the existing Integrated HAST audit tool that is used 
throughout the Western Cape Province in the primary care setting. Since the evaluation of the 
PMTCT service rendered to the HIV exposed infant is the only HAST programme that does not 
have a data collection tool as part of the Integrated HAST audit tool, it is recommended that it be 
incorporated as a component.  
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A training package will have to be developed for the PMTCT baby tool and this will include 
mock folders, registers and stationery so that participants can become familiar with where to find 
the data that is being reviewed. A manual will be developed that will serve as a guiding 
document for the user in preparation for and when conducting the review. It will provide 
information on sampling, where to search for the data that is required and how to complete the 
data collection tool. This will ensure reliability with the application of the tool.  
 
The Provincial HAST Audit task team will take responsibility for on-going review of the data 
collection tool. After each audit cycle they will assess validity of the tool and keep up to date 
with policy changes.  
 
6.2.2 Actions to improve PMTCT programme based on pilot 
Various recommendations that will ultimately improve the quality of the PMTCT service 
rendered to the HIV exposed infant, are put forward for implementation at the different service 
delivery levels and by different role-players.  
 
At facility management level 
At facility level, the staff should commence with the consistent implementation of the HIV 
Testing and Consent form for use with all mothers who must provide consent for the infant to 
have an HIV PCR test at 6 weeks. On testing HIV positive, the HIV / ART stationery should be 
implemented with immediate effect for the infant. The use of these two stationery items should 
be deemed non-negotiable and essential in order to ensure quality of care. 
 
The PMTCT Baby register makes provision for feeding practices to be recorded with every visit. 
Staff should be encouraged to make use of the register columns to record infant feeding with 
each visit. The register however, does not make provision for specific discussion around the 
feeding practices that should take place at each of these sessions. The stationery in the infant‟s 
folder also lacks prompts in terms of the detail around infant feeding. Staff must also be 
reminded that some infants are breastfed and that some mothers prefer to purchase their own 
formula, so in these instances formula milk will not be issued. In the event where the mother 
chooses to breastfeed, facility level staff needs to be mindful of the fact that the mother must be 
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Viral Load Suppressed and on ART. Should the mother select formula feeding, due 
consideration should be given in terms of her access to clean water, the knowledge on how to 
mix the formula, the ability to clean the infants bottles adequately and the understanding that 
inadequate hygiene practices do pose the risk of diarrhoea for the infant. 
 
In order to respond to the infant in an effective manner and in order to track the outcomes of all 
the PMTCT interventions (according to the policy), the HIV PCR result must be available in the 
infant folder. All efforts must be instituted at facility level to file the HIV PCR results within 24 
hours and to draw the clinical staff‟s attention to all HIV PCR positive results immediately. 
 
HAST programme staff at sub-structure level 
The data from the PMTCT Baby register is collated monthly to feed into the routine information 
system of the department of health. The accurate transfer of data from the folder to the register 
and the completeness of all the register data fields are crucial in order to facilitate programme 
reporting. The PMTCT coordinator should conduct training across the sub-structure on how to 
complete the register and then monitor the quality of register record-keeping on a monthly basis. 
 
Provincial HAST programme responsibility 
The coordination of training with regards to infant feeding for clinical staff and HIV counsellors 
must be prioritised. This will ensure standardisation of the message to the mother and reduce the 
risk of mixed feeding. 
 
A policy implementation guideline in terms of defining what is expected in the management plan 
for the PMTCT infant in terms of follow-up care, on-going care of the HIV positive mother and 
care of the infant post 6 week HIV PCR until 18 month HIV rapid test, is required. 
 
A group in collaboration with the Maternal, Child and Women‟s health programmes directorate, 
to address the cross-cutting issues that are covered in this tool, must be convened as a matter of 
urgency. 
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Appendix A: Comparison of PMTCT tools
Name of Tool
Area of PMTCT 
Number of 
Indicators
Domains covered
Source of 
Information
Community
PHC 
Facility
Hospital 
Setting
Community 
Field 
Worker
Nurse / 
Doctor
HIV Facility 
Counsellor
Other - 
Specify
Comment
1 Labour Ward Monthly data 
Summary Labour Ward 11
Quantity
Data & Service Quality Registers
X X X
Unpublished
2
Antenatal Data Validation Tool Antenatal Care 11
Quantity
Data & Service Quality Registers
X X
Unpublished
3 Module 9 PMTCT Programme 
Monitoring Tool fir Antenatal Care 
& Maternity Ward Register Tool
Antenatal Care
Labour Ward
16
Quantity
Data & Service Quality
Registers
X X X
4
Western Cape Provincial PMTCT 
Checklist
Antenatal Care
Labour Ward 14
Quality
Folders
X X X
Tool that serves as a 
checklist to enhance 
data quality & record-
keeping. Outdated!
5
Volunteers Follow-up Schedule for 
Expectant Mothers on HAART
Antenatal Care
Labour Ward
Baby Follow-up 12 Quality
Interviews
Support visits
X X
6
Volunteers Follow-up Schedule for 
Expectant Mothers on PMTCT
Antenatal Care
Intrapartum
Baby Follow-up 12 Quality
Interviews
Support visits
X X
7
FHI Baseline assessment tools for 
PMTCT of HIV
Antenatal Care
Intrapartum
Baby Follow-up 97
Access
Integration Interviews
X
PMTCT OR 
Project 
Manager
8
Evaluation of the Scale up of the 
PMTCT Infant feeding Counselling 
Training Programme in Tanzania
Antenatal Care
Baby Care
14
Access
Capacity: Staffing
Availability
Interviews
X Researchers
Large scale evaluation 
of all facilities in 
Tanzania wrt PMTCT 
in relation to Infant 
Feeding
9
PMTCT Folder Review of 
Antenatal Services - Integrated 
Audit Tool
Antenatal Care
19
Access
Quality
Capacity: Systems
Integration
Continuity of Care
Outcomes
Registers
Folders
X X
Unpublished
10
PMTCT Folder Review of 
Labouw Ward - Integrated Audit 
Tool Intrapartum 6
Access
Quality
Capacity: Systems
Integration
Continuity of Care
Outcomes
Registers
Folders
X X X
Unpublished
Level at which applicable
Evaluating the impact 
of CHWs on the 
PMTCT programme 
coverage and health 
outcomes. The focus is 
system strengthening 
and quality 
improvement.
For use by
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Appendix B:
 PMTCT: HIV Exposed Infants Care Folder Review Facility name:_______________________________________________Date: ____________________
Number of folders retrieved from the folder system ______________________ Number of folders requested for review  but not found in the folder system _____________
Ref
Folder 
1
Folder 
2
Folder 
3
Folder 
4
Folder 
5
Folder 
6
Folder 
7
Folder 
8
Folder 
9
Folder 
10
Folder 
11
Folder 
12
Folder 
13
Folder 
14
Folder 
15
Total 
Yes
Total 
No
Total 
N/A
Q 1 Has a counselling form been used?
Q 2 Was consent for an PCR test taken?
Q 3 Is the PCR result available in the folder?
Q 4
Is there a record that feeding options and mixed 
feeding w ere discussed at each visit?
Access 5
Was the full quota of infant feeding formula issued 
w ith each visit?
Access / Q 6
Was NVP supply checked and dosage adjusted w ith 
each visit?
Q 7
Is the information from the client's folder correctly 
entered into the PMTCT Baby register?
Q 8 Has the standard HIV/ARV stationery been used?
Q 9
Was a follow -up appointment and appropriate 
management plan noted at the last visit?
Q 10 Has the baby been referred for HAART
Q 11
Is there a record that w eight and urinalysis w as done 
at the last clinical visit?
Cont 12 Is there a record that the mother is receiving HAART?
Q / Cont 13
Did the mother have a CD 4 count done and are 
results available?
Q / Cont 14 Did the mother have WHO staging done?
Q / Cont 15 Has client been commenced on HAART?
Q / Int 16 Were condoms issued at the last clinical visit?
Cont 17
Was a follow -up appointment and appropriate 
management plan noted at the last visit?
Sampling procedure: PMTCT Baby Register, starting on a date 2 months ago and w orking backw ards, select sequential folders until you have 5 PCR-negative and 5 PCR -positive Baby -folders.  Exclude Babies w here the 
Mother declined PCR testing. Use the 10 folders to answ er questions 1 to 10.  Using a similar method, select an additional 5 HIV+ client folders for mother of babies irrespective of the babies PCR result.   The ten folders 
from HIV+ clients w ill be used to answ er questions 11 to 17.  Note any folders that are not possible to locate in the process.  Answ er Yes (Y), No (N) or Not Applicable (N/A) for each question.  Record any relevant other 
information on the back of the form.   
PCR NEGATIVE FOLDERS PCR POSITIVE FOLDERS SUMMARY RESULTS
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Appendix  C
 PMTCT: HIV Exposed Infants Care Folder Review Facility name:_______________________________________________
Number of folders retrieved from the folder system ______________________ Number of folders requested for review  but not found in the folder system _____________
Ref
Folder 
1
Folder 
2
Folder 
3
Folder 
4
Folder 
5
Folder 
6
Folder 
7
Folder 
8
Folder 
9
Folder 
10
Total 
Yes
Total 
No
Total 
N/A
Folder Number
Q 1 Has a counselling form been used?
Q 2 Was consent for an PCR test taken?
Q 3 Is the PCR result available in the folder?
Q 4 Has the standard HIV/ARV stationery been used? N/A N/A N/A N/A N/A
Q 5 Has the baby been commenced on HAART? [Evidence of start date] N/A N/A N/A N/A N/A
Q 6 Is there a record that feeding options w ere discussed at last visit?
>10 tins 8-10 tins <8 tins
Q Was the baby's w eighed and w eight recorded at last visit?
Access / Q 8
Was Co-trimoxazole issued at last visit and dosage adjusted according to 
w eight?
N/A N/A N/A N/A N/A
Access / Q 9
Was a follow -up appointment and appropriate management plan noted at the last 
visit?
Q 10
Is the information from the client's folder correctly entered into the PMTCT Baby 
register?
H-Q 1 Has the standard HIV/ARV stationery been used?
H-Q 2 Was a social assistance evaluation completed? 
H-Q 3 Has a RPR been done and are results available in the folder? 
H-Q 4 Has client had a pap smear done and results recorded?
H-Q 5
Did client undergo WHO clinical staging? (Baseline and if there has been a 
change *******in w hat? According to new  stationery?? Check w ith david p)
H-Q 6 Adult: Has a CD4 count been done as per CD4 protocol and are results available?
H-Q 7 Did client meet the medical criteria for ARVs?
H-Q 8 Has client been commenced on ARVs?
H-Q 9 Were condoms issued at the last clinical visit? (either male or female condoms)
H-Int 10
Were the contraceptive needs assessed at the last clinical visit & due date for 
repeats recorded?
H-Int 11
Is there a record of screening for TB at the last clinical visit? (minimum symptom 
screen of w eight loss and cough; appropriate tests done and recorded if 
symptomatic)
H-Int 12
Is there a record of screening for STI and appropriate treatment, if  required, at the 
last clinical visit?
H-Cont 13
Was a follow -up appointment and appropriate management plan noted at the last 
visit?
Sampling procedure: PMTCT Baby Register, starting on a date 2 months ago and w orking backw ards, select sequential folders until you have 7 PCR-negative and 3 PCR -positive Baby -folders.  Exclude Babies w here the 
Mother declined PCR testing. Use the 10 folders to answ er questions 1 to 10.  Select the folders of the 10 Mothers of the same babies to answ er questions 11 to 17.  Note any folders that are not possible to locate in the 
process.  Answ er Yes (Y), No (N) or Not Applicable (N/A) for each question.  Record any relevant other information on the back of the form.   
SUMMARY RESULTSPCR NEGATIVE FOLDERS PCR POSITIVE FOLDERS
Access 7 Was the full quota of infant feeding formula issued at the last visit?
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Facility name:___________________________________________     Date:______________________
Number of baby folders requested for review  but not found in the folder system _____________
Infant Folder Review s
Folder 
1
Folder 
2
Folder 
3
Folder 
4
Folder 
5
Folder 
6
Folder 
7
Folder 
8
Folder 
9
Folder 
10
Total 
Yes
Total 
No
Total 
N/A
PM TCT-
Q
1 Has an HIV consent and testing form been used for the HIV PCR test?
PM TCT-
Q
2 Was consent taken for the HIV PCR test?
PM TCT-
Q
3 Is the HIV PCR test result available in the folder?
PM TCT-
Q
4 Is there a record that feeding practice w as discussed at the last visit?
PM TCT-
Q
5 Was the baby w eighed and w eight recorded at the last visit?
PM TCT-
Q
6 Did the baby receive the birth, 6 and 10 w eek immunisations as per schedule?
PM TCT-
Cont
7 Was an appropriate management plan noted at the last visit?
PMTCT Baby Register Review
Folder 
1
Folder 
2
Folder 
3
Folder 
4
Folder 
5
Folder 
6
Folder 
7
Folder 
8
Folder 
9
Folder 
10
Total 
Yes
Total 
No
Total 
N/A
PM TCT-
Q
8
Is the 6 w eek PCR test result, cotrimoxazole at 6 w eeks, initial and ongoing 
feeding choice and provision of milk formula to date (w here applicable) correctly 
entered from the client's folder into the PMTCT Baby Register?
PM TCT-
Ac
9
Does the mother of this infant have her PHC folder number recorded in the PMTCT 
register?
PM TCT-
Ac
10 Does the mother of this infant have a CD4 result recorded in the PMTCT register?
Maternal Folder Review s
Folder 
1
Folder 
2
Folder 
3
Folder 
4
Folder 
5
Folder 
6
Folder 
7
Folder 
8
Folder 
9
Folder 
10
Total 
Yes
Total 
No
Total 
N/A
H-Ac 11 Is the mother identif ied as HIV-positive in the clinical folder?
H-Q 12 Has the standard HIV/ARV stationery been used?
H-Q 13 Is the mother’s baseline / current WHO clinical stage recorded?
H-Q 14 Has a CD4 count been done as per CD4 protocol and are results available?
H-Q 15 Does the mother currently meet the medical criteria for ART?
H-Q 16 Has mother been commenced on ART post-delivery?
H-Int 17
Were the contraceptive needs assessed at the last clinical visit & due date for 
repeats recorded?
H-Cont 18 Was an appropriate management plan noted at the last visit?
19
Appendix D
Sampling procedure: 
1. From the PMTCT Baby Register, start on a date 3 months ago and w ork backw ards.  Select sequential baby folders as follow s: If the clinic registers <10 babies per month, select every sequential folder; if  the clinics 
registers 10 or more babies per month select alternative folders.  Note the names of infants and their mothers in Annexure 9.  
2. If  any folder cannot be found, select a replacement using the same method until you have 10 baby folders to evaluate or have exceeded the 6 month cut-off.  Use these to answ er questions 1 to 7.  Answ er questions 8-
10 from the register for these babies and their mothers.  
3. For each baby w hose folder has been found, draw   the mother's folder. Exclude folders of mothers w ho w ere not see at the facility post-delivery.  Note the number of folder retrieved that meet criteria (seen post-
delivery at the facility), the number of folders found that fail criteria (not seen post-delivery) and the number of folders not found.  Use the maternal folders that meet crieria to answ er questions 11-18.  
4.  Answ er Yes (Y), No (N) or Not Applicable (N/A) for each question.  Record any relevant other information on the back of the form.   
SUMMARY RESULTS
 PMTCT: Postnatal Review
Number of baby folders retrieved from the folder system ______________________
Number of mother folders found that meet criteria:_______     Number of mother's folders found that fail (do not meet) criteria:_______     Number of mother folders not found:_______
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APPENDIX E 
UNIVERSITY OF THE WESTERN CAPE 
               School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
        
PARTICIPANT INFORMATION SHEET 
Development of a Tool to Evaluate the Quality of the Prevention of Mother to Child 
Transmission programme offered to the HIV exposed infants in the primary care 
facility setting in Cape Town 
 
 
Dear  
I am Juanita Olivia Arendse, a student at the University of the Western Cape. I am consulting 
experts in the HIV & AIDS, STI and TB arena so as to gather information related to the 
development the instrument that will evaluate the quality of the PMTCT services offered to the 
HIV exposed infants in the primary care setting.   
Why am I doing this? 
I am required to undertake a research project and submit a mini-thesis in partial fulfilment of the 
requirements for the degree Masters in Public Health in the School of Public Health (SOPH), 
University of the Western Cape. I will be carrying out expert panel discussions and am 
accountable to Dr Vera Scott (Supervisor, SOPH) who is contactable on +27 21 959 2630 or 
c/o SOPH Fax: +27 21 959 2809 or by email at vscott@mweb.co.za   
Who are the participants? 
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The participants are a group of local experts in the field of public primary care sector 
management of HIV services who will comprise the Core Task Team.  
 
What is expected from the participants in the study? 
I will ask you to attend a set of four group meetings (scheduled at the mutual convenience of the 
group). You will be asked to contribute your expertise on the subject of managing HIV 
programmes through structured, facilitated discussions with other group members. This will 
cover the purpose of the tool that is being developed, operational definitions, defining what the 
tool will and will not cover, desirable criteria for the tool, the choice of evaluation domains and 
indicators and the approach and content to be covered wrt training on the tool. Each expert panel 
discussion will last approximately 60 - 90 minutes. All the information collected will be treated 
confidentially, and only the researcher and supervisor will have access to it. 
What can participants expect? 
Once the research project is completed, feedback will be provided to all participants in the form 
of summarised and detailed reports as well a copy of the final tool.      
Can you withdraw from the study? 
Certainly, you may withdraw from the study at anytime, without having to give a reason. You 
are free to ask questions during the expert panel discussions. You do not have to talk about 
anything you do not want to, and you may exit from the expert panel discussion at any time. The 
study is voluntary and if you refuse to participate this will not influence your employment in any 
way. 
Any further questions? 
Are there any questions about what I have just explained? More information may be obtained 
from Juanita Olivia Arendse: who is contactable on +27 21 483 5751 or Fax: +27 21 483 6033 or 
by email at juani.mosesarendse@gmail.com. If you are willing to participate in the study, please 
read and sign the consent form below. 
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Appendix F 
UNIVERSITY OF THE WESTERN CAPE 
               School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
 
Participant’s agreement 
I have been informed about the purpose of the study, and what my participation involves. I also 
understand that I can withdraw from the study at any time, without having to give a reason and 
that the study is voluntary. I also understand that confidentiality will be maintained and that the 
findings of the study will be used for research purposes and service development. 
Researcher’s agreement 
I shall keep all the information collected during the research confidential and use a pseudonym 
of your choice in all documents. The contents will be used for the purposes referred to above, but 
may be used for published or unpublished research at a later stage without further consent. Any 
change from this agreement will be renegotiated with you. 
Participant‟s Signature: ________________________ Date: ____________________ 
Interviewer‟s Signature: ________________________ Date: ____________________ 
Dr Vera Scott (Supervisor, SoPH) is contactable on +27 21 959 2630 or c/o SOPH Fax: +27 
21 959 2809 or by email at vscott@mweb.co.za   
Consent Form 
Development of an Instrument to Evaluate the Quality of the Prevention of 
Mother to Child Transmission services offered to the HIV exposed infants in the 
primary care setting in Cape Town 
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Appendix G 
 
 
              
UNIVERSITY OF THE WESTERN CAPE 
               School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
        
PARTICIPANT INFORMATION SHEET 
Development of a Tool to Evaluate the Quality of the Prevention of Mother to Child 
Transmission programme offered to the HIV exposed infants in the primary care 
facility setting in Cape Town 
 
 
Dear  
I am Juanita Olivia Arendse, a student at the University of the Western Cape. I am consulting 
experts in the HIV & AIDS, STI and TB arena so as to gather information related to the 
development the instrument that will evaluate the quality of the PMTCT services offered to the 
HIV exposed infants in the primary care setting.   
Why am I doing this? 
I am required to undertake a research project and submit a mini-thesis in partial fulfilment of the 
requirements for the degree Masters in Public Health in the School of Public Health (SOPH), 
University of the Western Cape. I will be carrying out expert panel discussions and am 
accountable to Dr Vera Scott (Supervisor, SOPH) who is contactable on +27 21 959 2630 or 
c/o SOPH Fax: +27 21 959 2809 or by email at vscott@mweb.co.za   
Who are the participants? 
The participants are a group of facility managers, supervisors, HAST coordinators and facility 
level staff experienced in the HAST arena and willing to partake in piloting the tool at their 
facilities. These participants will comprise the group referred to as implementers.   
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What is expected from the participants in the study? 
I will ask you to attend a half day training session whereby you will comment on the tool that 
will evaluate the quality of the PMTCT programme offered to the HIV exposed infants in the 
South African primary care facility setting be piloted. You will also have the opportunity to 
comment on the need / usefulness for such a tool and its content. The training then aims to 
present the rationale and purpose of the tool, as well as clear any areas of ambiguity. You will 
then be required to be involved in the piloting of the tool and to provide feedback at the review 
session. 
All the information collected will be treated confidentially, and only the researcher and 
supervisor will have access to it. 
What can participants expect? 
Once the research project is completed, feedback will be provided to all participants in the form 
of summarised and detailed reports as well a copy of the final tool.      
Can you withdraw from the study? 
Certainly, you may withdraw from the study at anytime, without having to give a reason. You 
are free to ask questions during the training session and piloting stage.  You do not have to talk 
about anything you do not want to, and you may exit from the study at any time. The study is 
voluntary and if you refuse to participate this will not influence your employment in any way. 
Any further questions? 
Are there any questions about what I have just explained? More information may be obtained 
from Juanita Olivia Arendse: who is contactable on +27 21 483 5751 or Fax: +27 21 483 6033 or 
by email at juani.mosesarendse@gmail.com. If you are willing to participate in the study, please 
read and sign the consent form below. 
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Appendix H 
 
                
UNIVERSITY OF THE WESTERN CAPE 
               School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
 
Participant’s agreement 
I have been informed about the purpose of the study, and what my participation involves. I also 
understand that I can withdraw from the study at any time, without having to give a reason and 
that the study is voluntary. I also understand that confidentiality will be maintained and that the 
findings of the study will be used for research purposes and service development. 
Researcher’s agreement 
I shall keep all the information collected during the research confidential and use a pseudonym 
of your choice in all documents. The contents will be used for the purposes referred to above, but 
may be used for published or unpublished research at a later stage without further consent. Any 
change from this agreement will be renegotiated with you. 
Participant‟s Signature: ________________________ Date: ____________________ 
Interviewer‟s Signature: ________________________ Date: ____________________ 
Dr Vera Scott (Supervisor, SOPH) is contactable on +27 21 959 2630 or c/o SOPH Fax: +27 
21 959 2809 or by email at vscott@mweb.co.za 
Consent Form 
Development of an Instrument to Evaluate the Quality of the Prevention of 
Mother to Child Transmission services offered to the HIV exposed infants in the 
primary care setting in Cape Town 
 
 
 
 
 
